{ "instance": { "ocdx-10q_20210704.htm": { "axisCustom": 0, "axisStandard": 30, "contextCount": 385, "dts": { "calculationLink": { "local": [ "ocdx-20210704_cal.xml" ] }, "definitionLink": { "local": [ "ocdx-20210704_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "ocdx-10q_20210704.htm" ] }, "labelLink": { "local": [ "ocdx-20210704_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "ocdx-20210704_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml", "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "ocdx-20210704.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd" ] } }, "elementCount": 541, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2020-01-31": 6, "http://xbrl.sec.gov/dei/2020-01-31": 4, "total": 10 }, "keyCustom": 57, "keyStandard": 330, "memberCustom": 44, "memberStandard": 48, "nsprefix": "ocdx", "nsuri": "http://orthoclinical.com/20210704", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100090 - Disclosure - Basis of Presentation of the Unaudited Consolidated Financial Statements", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBasisOfPresentationOfUnauditedConsolidatedFinancialStatements", "shortName": "Basis of Presentation of the Unaudited Consolidated Financial Statements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100100 - Disclosure - Recent Accounting Pronouncements", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRecentAccountingPronouncements", "shortName": "Recent Accounting Pronouncements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100110 - Disclosure - Net Loss Per Share", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureNetLossPerShare", "shortName": "Net Loss Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100120 - Disclosure - Revenue", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenue", "shortName": "Revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100130 - Disclosure - Inventories", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureInventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100140 - Disclosure - Borrowings and Other Arrangements", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements", "shortName": "Borrowings and Other Arrangements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100160 - Disclosure - Collaborations and Other Relationships", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCollaborationsAndOtherRelationships", "shortName": "Collaborations and Other Relationships", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100170 - Disclosure - Income Taxes", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureIncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100180 - Disclosure - Stock-Based Compensation", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensation", "shortName": "Stock-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100190 - Disclosure - Segment and Geographic Information", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformation", "shortName": "Segment and Geographic Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100010 - Statement - Consolidated Statements of Operations (Unaudited)", "role": "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited", "shortName": "Consolidated Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-5", "lang": null, "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "ocdx:NoncashInvestingAndFinancingActivitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100200 - Disclosure - Noncash Investing and Financing Activities", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureNoncashInvestingAndFinancingActivities", "shortName": "Noncash Investing and Financing Activities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "ocdx:NoncashInvestingAndFinancingActivitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100210 - Disclosure - Related Party Transactions", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100220 - Disclosure - Commitments and Contingencies", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100230 - Disclosure - Fair Value Measurements", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureFairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100240 - Disclosure - Derivative Instruments and Hedging Activities", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivities", "shortName": "Derivative Instruments and Hedging Activities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100250 - Disclosure - Accumulated Other Comprehensive Income (Loss)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLoss", "shortName": "Accumulated Other Comprehensive Income (Loss)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherOperatingIncomeAndExpenseTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100260 - Disclosure - Other Expense, Net", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureOtherExpenseNet", "shortName": "Other Expense, Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherOperatingIncomeAndExpenseTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100270 - Disclosure - Net Loss Per Share (Tables)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureNetLossPerShareTables", "shortName": "Net Loss Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100280 - Disclosure - Revenue (Tables)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100290 - Disclosure - Inventories (Tables)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureInventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100020 - Statement - Consolidated Statements of Comprehensive Loss (Unaudited)", "role": "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited", "shortName": "Consolidated Statements of Comprehensive Loss (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-5", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100300 - Disclosure - Borrowings and Other Arrangements (Tables)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsTables", "shortName": "Borrowings and Other Arrangements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "ocdx:ScheduleOfCashAndCashEquivalentsRestrictedCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100310 - Disclosure - Supplemental Balance Sheet Information (Tables)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationTables", "shortName": "Supplemental Balance Sheet Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "ocdx:ScheduleOfCashAndCashEquivalentsRestrictedCashAndCashEquivalentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100320 - Disclosure - Stock-Based Compensation (Tables)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationTables", "shortName": "Stock-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100330 - Disclosure - Segment and Geographic Information (Tables)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationTables", "shortName": "Segment and Geographic Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100340 - Disclosure - Fair Value Measurements (Tables)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureFairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100350 - Disclosure - Derivative Instruments and Hedging Activities (Tables)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesTables", "shortName": "Derivative Instruments and Hedging Activities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "us-gaap:ComprehensiveIncomeNoteTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100360 - Disclosure - Accumulated Other Comprehensive Income (Loss) (Tables)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossTables", "shortName": "Accumulated Other Comprehensive Income (Loss) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ComprehensiveIncomeNoteTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100370 - Disclosure - General and Description of the Business - Additional Information (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "shortName": "General and Description of the Business - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:NatureOfOperations", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapCreditFacilityAxis_ocdxDollarTermLoanFacilityMember_20210201_20210228", "decimals": "-5", "lang": null, "name": "us-gaap:RepaymentsOfSeniorDebt", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210118_20210118", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesStockSplits", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100380 - Disclosure - Basis of Presentation of the Unaudited Consolidated Financial Statements - Additional Information (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBasisOfPresentationOfUnauditedConsolidatedFinancialStatementsAdditionalInformationDetails", "shortName": "Basis of Presentation of the Unaudited Consolidated Financial Statements - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210118_20210118", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesStockSplits", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201912Member_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100390 - Disclosure - Recent Accounting Pronouncements - Additional Information (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRecentAccountingPronouncementsAdditionalInformationDetails", "shortName": "Recent Accounting Pronouncements - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201912Member_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100030 - Statement - Consolidated Balance Sheets (Unaudited)", "role": "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited", "shortName": "Consolidated Balance Sheets (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210704", "decimals": "-5", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100400 - Disclosure - Net Loss Per Share - Summary of Potential Gross Ordinary Shares Equivalent Excluded from Computation of Net Loss per Share (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureNetLossPerShareSummaryOfPotentialGrossOrdinarySharesEquivalentExcludedFromComputationOfNetLossPerShareDetails", "shortName": "Net Loss Per Share - Summary of Potential Gross Ordinary Shares Equivalent Excluded from Computation of Net Loss per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "ocdx:MinimumReagentPurchasesLeaseTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100410 - Disclosure - Revenue - Additional Information (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails", "shortName": "Revenue - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "ocdx:MinimumReagentPurchasesLeaseTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerAssetNet", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100420 - Disclosure - Revenue - Schedule of Balance of Contract Assets Recorded in Consolidated Balance Sheets (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueScheduleOfBalanceOfContractAssetsRecordedInConsolidatedBalanceSheetsDetails", "shortName": "Revenue - Schedule of Balance of Contract Assets Recorded in Consolidated Balance Sheets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapBalanceSheetLocationAxis_us-gaapOtherCurrentAssetsMember_20210704", "decimals": "-5", "lang": null, "name": "us-gaap:ContractWithCustomerAssetNet", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100430 - Disclosure - Revenue - Summary of Net Revenue by Line of Business (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails", "shortName": "Revenue - Summary of Net Revenue by Line of Business (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsAndSupplies", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100440 - Disclosure - Inventories - Schedule of Inventories (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails", "shortName": "Inventories - Schedule of Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsAndSupplies", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FinanceLeaseLiability", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100450 - Disclosure - Borrowings and Other Arrangements - Components of Borrowings (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails", "shortName": "Borrowings and Other Arrangements - Components of Borrowings (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:FinanceLeaseLiability", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100470 - Disclosure - Borrowings and Other Arrangements - Senior Secured Credit Facilities - Additional Information (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails", "shortName": "Borrowings and Other Arrangements - Senior Secured Credit Facilities - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapCreditFacilityAxis_ocdxDollarTermLoanFacilityMember_20210201_20210228", "decimals": "-5", "lang": null, "name": "us-gaap:EarlyRepaymentOfSeniorDebt", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100480 - Disclosure - Borrowings and Other Arrangements - 2025 Notes - Additional Information (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "shortName": "Borrowings and Other Arrangements - 2025 Notes - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapLongtermDebtTypeAxis_ocdxSevenPointThreeSevenFivePercentSeniorNotesDueTwoThousandTwentyFiveMember_20200611", "decimals": "INF", "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapLongtermDebtTypeAxis_ocdxSevenPointThreeSevenFivePercentSeniorNotesDueTwoThousandTwentyFiveMember_20200611_20200611", "decimals": "5", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentRedemptionPricePercentage", "reportCount": 1, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100490 - Disclosure - Borrowings and Other Arrangements - Schedule of Redemption Prices of 2025 Notes Expressed as Percentages of Principal Amount (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails", "shortName": "Borrowings and Other Arrangements - Schedule of Redemption Prices of 2025 Notes Expressed as Percentages of Principal Amount (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:DebtInstrumentRedemptionTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapDebtInstrumentRedemptionPeriodAxis_us-gaapDebtInstrumentRedemptionPeriodOneMember_us-gaapLongtermDebtTypeAxis_ocdxSevenPointThreeSevenFivePercentSeniorNotesDueTwoThousandTwentyFiveMember_20210104_20210704", "decimals": "5", "lang": null, "name": "us-gaap:DebtInstrumentRedemptionPricePercentage", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100500 - Disclosure - Borrowings and Other Arrangements - 2028 Notes - Additional Information (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails", "shortName": "Borrowings and Other Arrangements - 2028 Notes - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapLongtermDebtTypeAxis_ocdxSevenPointTwoFiveZeroPercentSeniorNotesDueTwoThousandTwentyEightMember_20200127", "decimals": "INF", "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100040 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical)", "role": "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnauditedParenthetical", "shortName": "Consolidated Balance Sheets (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapLongtermDebtTypeAxis_ocdxSevenPointTwoFiveZeroPercentSeniorNotesDueTwoThousandTwentyEightMember_20200127_20200127", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentRedemptionPricePercentage", "reportCount": 1, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100510 - Disclosure - Borrowings and Other Arrangements - Schedule of Redemption Prices of 2028 Notes Expressed as Percentages of Principal Amount (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails", "shortName": "Borrowings and Other Arrangements - Schedule of Redemption Prices of 2028 Notes Expressed as Percentages of Principal Amount (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:DebtInstrumentRedemptionTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapDebtInstrumentRedemptionPeriodAxis_us-gaapDebtInstrumentRedemptionPeriodTwoMember_us-gaapLongtermDebtTypeAxis_ocdxSevenPointTwoFiveZeroPercentSeniorNotesDueTwoThousandTwentyEightMember_20210104_20210704", "decimals": "5", "lang": null, "name": "us-gaap:DebtInstrumentRedemptionPricePercentage", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100520 - Disclosure - Borrowings and Other Arrangements - 2022 Notes - Additional Information (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2022NotesAdditionalInformationDetails", "shortName": "Borrowings and Other Arrangements - 2022 Notes - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapLongtermDebtTypeAxis_ocdxSixPointSixTwoFivePercentSeniorNotesDueTwoThousandTwentyTwoMember_20200128", "decimals": "-8", "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20160601_20160630", "decimals": "-5", "first": true, "lang": null, "name": "ocdx:SaleAndLeasebackFinancingAssetsSold", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100530 - Disclosure - Borrowings and Other Arrangements - Sale and Leaseback Financing - Additional Information (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSaleAndLeasebackFinancingAdditionalInformationDetails", "shortName": "Borrowings and Other Arrangements - Sale and Leaseback Financing - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20160601_20160630", "decimals": "-5", "first": true, "lang": null, "name": "ocdx:SaleAndLeasebackFinancingAssetsSold", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapLongtermDebtTypeAxis_ocdxAccountsReceivableFinancingMember_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentMaturityDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100540 - Disclosure - Borrowings and Other Arrangements - Accounts Receivable Financing - Additional Information (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails", "shortName": "Borrowings and Other Arrangements - Accounts Receivable Financing - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapLongtermDebtTypeAxis_ocdxAccountsReceivableFinancingMember_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentMaturityDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ocdx:InterestExpenseDebtNetTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AmortizationOfFinancingCosts", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100550 - Disclosure - Borrowings and Other Arrangements - Schedule of Interest Expense, Net (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails", "shortName": "Borrowings and Other Arrangements - Schedule of Interest Expense, Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ocdx:InterestExpenseDebtNetTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AmortizationOfFinancingCosts", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100560 - Disclosure - Borrowings and Other Arrangements - Schedule of Required Future Repayments of all Borrowings Outstanding (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails", "shortName": "Borrowings and Other Arrangements - Schedule of Required Future Repayments of all Borrowings Outstanding (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100570 - Disclosure - Supplemental Balance Sheet Information - Schedule of Cash and Cash Equivalents and Restricted Cash (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfCashAndCashEquivalentsAndRestrictedCashDetails", "shortName": "Supplemental Balance Sheet Information - Schedule of Cash and Cash Equivalents and Restricted Cash (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ocdx:ScheduleOfCashAndCashEquivalentsRestrictedCashAndCashEquivalentsTableTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210704", "decimals": "-5", "lang": null, "name": "us-gaap:RestrictedCashEquivalentsNoncurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100580 - Disclosure - Supplemental Balance Sheet Information - Schedule of Accrued Liabilities (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfAccruedLiabilitiesDetails", "shortName": "Supplemental Balance Sheet Information - Schedule of Accrued Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ResearchAndDevelopmentExpense", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100590 - Disclosure - Collaborations and Other Relationships - Additional Information (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "shortName": "Collaborations and Other Relationships - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CollaborativeArrangementDisclosureTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_srtCounterpartyNameAxis_ocdxGrifolsDiagnosticSolutionsIncMember_us-gaapTypeOfArrangementAxis_ocdxJointBusinessMember_20210405_20210704", "decimals": "-5", "lang": null, "name": "ocdx:NetProfitSharedUnderJointVentureBeforeTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100600 - Disclosure - Income Taxes - Additional Information (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "shortName": "Income Taxes - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20191229", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100050 - Statement - Consolidated Statements of Changes in Shareholders' Equity (Deficit) (Unaudited)", "role": "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited", "shortName": "Consolidated Statements of Changes in Shareholders' Equity (Deficit) (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20191229", "decimals": "-6", "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100610 - Disclosure - Stock-Based Compensation - Schedule of Stock-Based Compensation Under Statements Of Operations (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockBasedCompensationUnderStatementsOfOperationsDetails", "shortName": "Stock-Based Compensation - Schedule of Stock-Based Compensation Under Statements Of Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "ocdx:AdditionalStockBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100620 - Disclosure - Stock-Based Compensation - Additional Information (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails", "shortName": "Stock-Based Compensation - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapAwardTypeAxis_us-gaapRestrictedStockMember_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "ocdx:AdditionalStockBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "U_ocdxSegment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100630 - Disclosure - Segment and Geographic Information - Additional Information (Detail)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationAdditionalInformationDetail", "shortName": "Segment and Geographic Information - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "U_ocdxSegment", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100640 - Disclosure - Segment and Geographic Information - Net Revenue by Segment (Detail)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail", "shortName": "Segment and Geographic Information - Net Revenue by Segment (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_srtStatementGeographicalAxis_ocdxOtherMember_20210405_20210704", "decimals": "-5", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "ocdx:AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100650 - Disclosure - Segment and Geographic Information - Adjusted EBITDA by Segment (Detail)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "shortName": "Segment and Geographic Information - Adjusted EBITDA by Segment (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_srtConsolidationItemsAxis_us-gaapOperatingSegmentsMember_srtStatementGeographicalAxis_srtAmericasMember_20210405_20210704", "decimals": "-5", "lang": null, "name": "ocdx:AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100660 - Disclosure - Segment and Geographic Information - Reconciliation of Net Loss to Adjusted EBITDA (Detail)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationReconciliationOfNetLossToAdjustedEBITDADetail", "shortName": "Segment and Geographic Information - Reconciliation of Net Loss to Adjusted EBITDA (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-5", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "p", "ocdx:NoncashInvestingAndFinancingActivitiesTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": "-5", "first": true, "lang": null, "name": "ocdx:NoncashTransferOfInventoryToPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100670 - Disclosure - Noncash Investing and Financing Activities - Additional Information (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureNoncashInvestingAndFinancingActivitiesAdditionalInformationDetails", "shortName": "Noncash Investing and Financing Activities - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ocdx:NoncashInvestingAndFinancingActivitiesTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": "-5", "first": true, "lang": null, "name": "ocdx:NoncashTransferOfInventoryToPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100680 - Disclosure - Related Party Transactions - Additional Information (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "shortName": "Related Party Transactions - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_ocdxCarlyleInvestmentManagementLLCMember_20210405_20210704", "decimals": "-5", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapCreditFacilityAxis_ocdxDollarTermLoanFacilityMember_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LongTermDebtFairValue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100690 - Disclosure - Fair Value Measurements - Schedule of Fair Values of Long-term Borrowings (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFairValuesOfLongTermBorrowingsDetails", "shortName": "Fair Value Measurements - Schedule of Fair Values of Long-term Borrowings (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapCreditFacilityAxis_ocdxDollarTermLoanFacilityMember_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LongTermDebtFairValue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100700 - Disclosure - Derivative Instruments and Hedging Activities - Additional Information (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "shortName": "Derivative Instruments and Hedging Activities - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapCreditFacilityAxis_ocdxEuroTermLoanFacilityMember_20210704", "decimals": "-6", "lang": null, "name": "us-gaap:NetInvestmentHedgeDerivativeLiabilitiesAtFairValue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217EUR", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapDerivativeInstrumentRiskAxis_us-gaapForeignExchangeForwardMember_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100060 - Statement - Consolidated Statements of Changes in Shareholders' Equity (Deficit) (Unaudited) (Parenthetical)", "role": "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnauditedParenthetical", "shortName": "Consolidated Statements of Changes in Shareholders' Equity (Deficit) (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapDerivativeInstrumentRiskAxis_us-gaapForeignExchangeForwardMember_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaapCashFlowHedgingMember_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "ocdx:InterestRateDerivativeAgreementsEffectiveDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100710 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Interest Rate Derivative Agreements (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Interest Rate Derivative Agreements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaapCashFlowHedgingMember_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "ocdx:InterestRateDerivativeAgreementsEffectiveDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaapCashFlowHedgingMember_20210704", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100720 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Interest Rate Derivative Agreements (Parenthetical) (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsParentheticalDetails", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Interest Rate Derivative Agreements (Parenthetical) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapDerivativeInstrumentRiskAxis_ocdxExpectedNotionalValueTwoThousandTwentyTwoMember_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaapCashFlowHedgingMember_20210704", "decimals": "INF", "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfInterestRateDerivativesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaapCashFlowHedgingMember_20210704", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100730 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Currency Hedging Instruments Outstanding (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Currency Hedging Instruments Outstanding (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ocdx:ScheduleOfForeignCurrencyForwardContractsOutstanding", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapDerivativeInstrumentRiskAxis_us-gaapForeignExchangeForwardMember_us-gaapHedgingDesignationAxis_us-gaapNondesignatedMember_20210704", "decimals": "INF", "lang": null, "name": "us-gaap:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapDerivativeInstrumentRiskAxis_us-gaapForeignExchangeForwardMember_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaapCashFlowHedgingMember_us-gaapHedgingDesignationAxis_us-gaapDesignatedAsHedgingInstrumentMember_us-gaapIncomeStatementLocationAxis_ocdxCostOfRevenueExcludingAmortizationOfIntangibleAssetsMember_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100740 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Gains and Losses from Designated Derivative and Non-derivative Instruments within AOCI (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Gains and Losses from Designated Derivative and Non-derivative Instruments within AOCI (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapDerivativeInstrumentRiskAxis_us-gaapForeignExchangeForwardMember_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaapCashFlowHedgingMember_us-gaapHedgingDesignationAxis_us-gaapDesignatedAsHedgingInstrumentMember_us-gaapIncomeStatementLocationAxis_ocdxCostOfRevenueExcludingAmortizationOfIntangibleAssetsMember_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapDerivativeInstrumentRiskAxis_us-gaapInterestRateContractMember_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaapCashFlowHedgingMember_us-gaapHedgingDesignationAxis_us-gaapDesignatedAsHedgingInstrumentMember_us-gaapIncomeStatementLocationAxis_us-gaapInterestExpenseMember_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100750 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Gains and Losses from Designated Derivative and Non-derivative Instruments within AOCI (Parenthetical) (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIParentheticalDetails", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Gains and Losses from Designated Derivative and Non-derivative Instruments within AOCI (Parenthetical) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapDerivativeInstrumentRiskAxis_us-gaapInterestRateContractMember_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaapCashFlowHedgingMember_us-gaapHedgingDesignationAxis_us-gaapDesignatedAsHedgingInstrumentMember_us-gaapIncomeStatementLocationAxis_us-gaapInterestExpenseMember_20191230_20200628", "decimals": "-5", "lang": null, "name": "ocdx:CumulativeEffectOfChangeInAccountingStandard", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:InterestExpense", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100760 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Designated Derivative Instruments within Interest Expense, Net and Cost of Revenue, Excluding Amortization of Intangible Assets in Statements of Operations (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueExcludingAmortizationOfIntangibleAssetsInStatementsOfOperationsDetails", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Designated Derivative Instruments within Interest Expense, Net and Cost of Revenue, Excluding Amortization of Intangible Assets in Statements of Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaapCashFlowHedgingMember_20210405_20210704", "decimals": "-5", "lang": null, "name": "us-gaap:InterestExpense", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapHedgingDesignationAxis_us-gaapNondesignatedMember_us-gaapIncomeStatementLocationAxis_us-gaapOtherNonoperatingIncomeExpenseMember_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100770 - Disclosure - Derivative Instruments and Hedging Activities - Schedule of Mark-to-Market (Gains) and Losses on Non-Designated Derivatives Recognized (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfMarkToMarketGainsAndLossesOnNonDesignatedDerivativesRecognizedDetails", "shortName": "Derivative Instruments and Hedging Activities - Schedule of Mark-to-Market (Gains) and Losses on Non-Designated Derivatives Recognized (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapHedgingDesignationAxis_us-gaapNondesignatedMember_us-gaapIncomeStatementLocationAxis_us-gaapOtherNonoperatingIncomeExpenseMember_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapBalanceSheetLocationAxis_ocdxAccruedLiabilitiesCurrentMember_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaapCashFlowHedgingMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapHedgingDesignationAxis_us-gaapDesignatedAsHedgingInstrumentMember_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:InterestRateFairValueHedgeLiabilityAtFairValue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100780 - Disclosure - Derivative Instruments and Hedging Activities - Location and Fair Values of Designated Hedging Instruments Recognized within Consolidated Balance Sheets (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "shortName": "Derivative Instruments and Hedging Activities - Location and Fair Values of Designated Hedging Instruments Recognized within Consolidated Balance Sheets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapBalanceSheetLocationAxis_ocdxAccruedLiabilitiesCurrentMember_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaapCashFlowHedgingMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapHedgingDesignationAxis_us-gaapDesignatedAsHedgingInstrumentMember_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:InterestRateFairValueHedgeLiabilityAtFairValue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapBalanceSheetLocationAxis_ocdxAccruedLiabilitiesCurrentMember_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaapCashFlowHedgingMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapHedgingDesignationAxis_us-gaapNondesignatedMember_20210704", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:InterestRateFairValueHedgeLiabilityAtFairValue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100790 - Disclosure - Derivative Instruments and Hedging Activities - Location and Fair Values of Non-Designated Hedging Instruments Recognized within Consolidated Balance Sheets (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "shortName": "Derivative Instruments and Hedging Activities - Location and Fair Values of Non-Designated Hedging Instruments Recognized within Consolidated Balance Sheets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapBalanceSheetLocationAxis_ocdxAccruedLiabilitiesCurrentMember_us-gaapDerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaapCashFlowHedgingMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel2Member_us-gaapHedgingDesignationAxis_us-gaapNondesignatedMember_20210704", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:InterestRateFairValueHedgeLiabilityAtFairValue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210404", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100800 - Disclosure - Accumulated Other Comprehensive Income (Loss) - Summary of Accumulated Other Comprehensive Income (Loss), Net of Tax (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails", "shortName": "Accumulated Other Comprehensive Income (Loss) - Summary of Accumulated Other Comprehensive Income (Loss), Net of Tax (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "us-gaap:ComprehensiveIncomeNoteTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_us-gaapStatementEquityComponentsAxis_us-gaapAccumulatedDefinedBenefitPlansAdjustmentMember_20210404", "decimals": "-5", "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100070 - Statement - Consolidated Statements of Cash Flows", "role": "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:OtherNonoperatingIncomeExpense", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100810 - Disclosure - Other Expense, Net - Additional Information (Details)", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureOtherExpenseNetAdditionalInformationDetails", "shortName": "Other Expense, Net - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:OtherOperatingIncomeAndExpenseTextBlock", "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210405_20210704", "decimals": "-5", "lang": null, "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100080 - Disclosure - General and Description of the Business", "role": "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusiness", "shortName": "General and Description of the Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ocdx-10q_20210704.htm", "contextRef": "C_0001828443_20210104_20210704", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 95, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "verboseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r561" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r562" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r563" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r563" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r563" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r564" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r563" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r563" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r563" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r563" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r559" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r560" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "ocdx_AccountsReceivableFinancingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounts receivable financing.", "label": "Accounts Receivable Financing [Member]", "terseLabel": "Accounts Receivable Financing", "verboseLabel": "Financing Program" } } }, "localname": "AccountsReceivableFinancingMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails" ], "xbrltype": "domainItemType" }, "ocdx_AccruedCommissionAndRebate": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfAccruedLiabilitiesDetails": { "order": 10030.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued commission and rebate.", "label": "Accrued Commission And Rebate", "terseLabel": "Accrued commissions and rebates" } } }, "localname": "AccruedCommissionAndRebate", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_AccruedLiabilitiesCurrentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accrued liabilities current.", "label": "Accrued Liabilities Current [Member]", "terseLabel": "Accrued Liabilities" } } }, "localname": "AccruedLiabilitiesCurrentMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "ocdx_AdditionalAwardsGrantedPotentialPaymentReceivableForDevelopmentAndSubmissionOfEmergencyUseAuthorizationsAnd510KApplicationsOfCOVID19Tests": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Additional awards granted, potential payment receivable for development and submission of emergency use authorizations and 510(k) applications of COVID-19 tests.", "label": "Additional Awards Granted Potential Payment Receivable For Development And Submission Of Emergency Use Authorizations And510 K Applications Of C O V I D19 Tests", "terseLabel": "Additional awards granted, potential payment receivable for development and submission of emergency use authorizations and 510(k) applications of COVID-19 tests" } } }, "localname": "AdditionalAwardsGrantedPotentialPaymentReceivableForDevelopmentAndSubmissionOfEmergencyUseAuthorizationsAnd510KApplicationsOfCOVID19Tests", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_AdditionalStockBasedCompensationExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Additional stock-based compensation expense.", "label": "Additional Stock Based Compensation Expense", "terseLabel": "Additional stock-based compensation expense" } } }, "localname": "AdditionalStockBasedCompensationExpense", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_AdditionalStockSharesIssuedForEachShareOfExistingShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional stock shares issued for each share of existing share.", "label": "Additional Stock Shares Issued For Each Share Of Existing Share", "terseLabel": "Additional share for each existing share" } } }, "localname": "AdditionalStockSharesIssuedForEachShareOfExistingShare", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBasisOfPresentationOfUnauditedConsolidatedFinancialStatementsAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "ocdx_AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjusted earnings before interest, tax, depreciation and amortization.", "label": "Adjusted Earnings Before Interest Tax Depreciation And Amortization", "terseLabel": "Adjusted EBITDA", "verboseLabel": "Adjusted EBITDA" } } }, "localname": "AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationReconciliationOfNetLossToAdjustedEBITDADetail" ], "xbrltype": "monetaryItemType" }, "ocdx_BasisPointStepDownsOfFirstLienNetLeverageRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basis point step-downs of first lien net leverage ratio.", "label": "Basis Point Step Downs Of First Lien Net Leverage Ratio", "terseLabel": "Basis point step-downs of first lien net leverage ratio" } } }, "localname": "BasisPointStepDownsOfFirstLienNetLeverageRatio", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "pureItemType" }, "ocdx_BasisPointStepDownsOnInterestRateOfFirstLienNetLeverageRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basis point step-downs on interest rate of first lien net leverage ratio.", "label": "Basis Point Step Downs On Interest Rate Of First Lien Net Leverage Ratio", "terseLabel": "Basis point step-downs on interest rate of first lien net leverage ratio" } } }, "localname": "BasisPointStepDownsOnInterestRateOfFirstLienNetLeverageRatio", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_BiomedicalAdvancedResearchAndDevelopmentAuthorityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Biomedical advanced research and development authority.", "label": "Biomedical Advanced Research And Development Authority [Member]", "terseLabel": "Biomedical Advanced Research and Development Authority" } } }, "localname": "BiomedicalAdvancedResearchAndDevelopmentAuthorityMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_CarlyleInvestmentManagementLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Carlyle Investment Management, L.L.C.", "label": "Carlyle Investment Management L L C [Member]", "terseLabel": "Carlyle Investment Management, L.L.C." } } }, "localname": "CarlyleInvestmentManagementLLCMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_ClinicalLaboratoriesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Clinical laboratories.", "label": "Clinical Laboratories [Member]", "terseLabel": "Clinical Laboratories" } } }, "localname": "ClinicalLaboratoriesMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails" ], "xbrltype": "domainItemType" }, "ocdx_ConsultingFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Consulting fee.", "label": "Consulting Fee", "terseLabel": "Consulting fees" } } }, "localname": "ConsultingFee", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_ConsultingServiceAgreementPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consulting service agreement period.", "label": "Consulting Service Agreement Period", "terseLabel": "Agreement, initial term" } } }, "localname": "ConsultingServiceAgreementPeriod", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "ocdx_ConsultingServicesAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consulting services agreement.", "label": "Consulting Services Agreement [Member]", "terseLabel": "Consulting Services Agreement" } } }, "localname": "ConsultingServicesAgreementMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_ContractManufacturingAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contract manufacturing agreements.", "label": "Contract Manufacturing Agreements [Member]", "terseLabel": "Contract Manufacturing Agreements" } } }, "localname": "ContractManufacturingAgreementsMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_ContractualArrangementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contractual arrangements.", "label": "Contractual Arrangements [Member]", "terseLabel": "Contractual Arrangements" } } }, "localname": "ContractualArrangementsMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_CostOfRevenueExcludingAmortizationOfIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cost of revenue excluding amortization of intangible assets.", "label": "Cost Of Revenue Excluding Amortization Of Intangible Assets [Member]", "terseLabel": "Cost of Revenue Excluding Amortization of Intangible Assets" } } }, "localname": "CostOfRevenueExcludingAmortizationOfIntangibleAssetsMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueExcludingAmortizationOfIntangibleAssetsInStatementsOfOperationsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails" ], "xbrltype": "domainItemType" }, "ocdx_CrossCurrencySwapsFairValueHedgeAssetAtFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cross currency swaps fair value hedge asset at fair value.", "label": "Cross Currency Swaps Fair Value Hedge Asset At Fair Value", "terseLabel": "Cross-currency interest rate swap contracts" } } }, "localname": "CrossCurrencySwapsFairValueHedgeAssetAtFairValue", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_CumulativeEffectOfChangeInAccountingStandard": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails": { "order": 10030.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cumulative effect of change in accounting standard.", "label": "Cumulative Effect Of Change In Accounting Standard", "terseLabel": "Cumulative effect of change in accounting standard", "verboseLabel": "Loss from cumulative effect of change in accounting standard" } } }, "localname": "CumulativeEffectOfChangeInAccountingStandard", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_CustomerSupplyAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer supply agreement.", "label": "Customer Supply Agreement [Member]", "terseLabel": "Customer Supply Agreement" } } }, "localname": "CustomerSupplyAgreementMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_DebtInstrumentRedemptionPeriodSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument, redemption period seven.", "label": "Debt Instrument Redemption Period Seven [Member]", "terseLabel": "Prior to February 1, 2023" } } }, "localname": "DebtInstrumentRedemptionPeriodSevenMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_DebtInstrumentRedemptionPeriodSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt instrument, redemption period six.", "label": "Debt Instrument Redemption Period Six [Member]", "terseLabel": "Prior to June 1, 2022" } } }, "localname": "DebtInstrumentRedemptionPeriodSixMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_DerivativeInstrumentsAndOtherNet": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails": { "order": 10100.0, "parentTag": "us-gaap_InterestExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Derivative instruments and other Net.", "label": "Derivative Instruments And Other Net", "terseLabel": "Derivative instruments and other" } } }, "localname": "DerivativeInstrumentsAndOtherNet", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_DerivativeInstrumentsDeferredLossesReleasedToInterestExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Derivative instruments deferred losses released to interest expense.", "label": "Derivative Instruments Deferred Losses Released To Interest Expense", "terseLabel": "Deferred losses released to interest expense" } } }, "localname": "DerivativeInstrumentsDeferredLossesReleasedToInterestExpense", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_DerivativeInterestRateReceived": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative interest rate received.", "label": "Derivative Interest Rate Received", "terseLabel": "Interest rate received" } } }, "localname": "DerivativeInterestRateReceived", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails" ], "xbrltype": "percentItemType" }, "ocdx_DescriptionOfFloatingRateDerivativeActivities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of floating rate derivative activities.", "label": "Description Of Floating Rate Derivative Activities", "terseLabel": "Floating rate" } } }, "localname": "DescriptionOfFloatingRateDerivativeActivities", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails" ], "xbrltype": "stringItemType" }, "ocdx_DollarTermLoanFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dollar term loan facility.", "label": "Dollar Term Loan Facility [Member]", "terseLabel": "Dollar Term Loan Facility" } } }, "localname": "DollarTermLoanFacilityMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFairValuesOfLongTermBorrowingsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_EachFiscalQuarterEndingAfterJuneThirtyTwoThousandTwentyOneAndOnOrBeforeSeptemberThirtyTwoThousandTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Each fiscal quarter ending after June thirty, two thousand twenty one and on or before September thirty, two thousand twenty two [Member]", "label": "Each Fiscal Quarter Ending After June Thirty Two Thousand Twenty One And On Or Before September Thirty Two Thousand Twenty Two [Member]", "terseLabel": "Each Fiscal Quarter Ending after June 30, 2021 and on or Prior to September 30, 2022" } } }, "localname": "EachFiscalQuarterEndingAfterJuneThirtyTwoThousandTwentyOneAndOnOrBeforeSeptemberThirtyTwoThousandTwentyTwoMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_EachFiscalQuarterEndingThereafterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Each fiscal quarter ending thereafter.", "label": "Each Fiscal Quarter Ending Thereafter [Member]", "terseLabel": "Each Fiscal Quarter Ending Thereafter" } } }, "localname": "EachFiscalQuarterEndingThereafterMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_EuroTermLoanFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Euro term loan facility.", "label": "Euro Term Loan Facility [Member]", "terseLabel": "Euro Term Loan Facility" } } }, "localname": "EuroTermLoanFacilityMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFairValuesOfLongTermBorrowingsDetails" ], "xbrltype": "domainItemType" }, "ocdx_ExpectedNotionalValueTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expected notional value two thousand twenty three.", "label": "Expected Notional Value Two Thousand Twenty Three [Member]", "terseLabel": "Expected Notional Value 2023" } } }, "localname": "ExpectedNotionalValueTwoThousandTwentyThreeMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsParentheticalDetails" ], "xbrltype": "domainItemType" }, "ocdx_ExpectedNotionalValueTwoThousandTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expected notional value two thousand twenty two.", "label": "Expected Notional Value Two Thousand Twenty Two [Member]", "terseLabel": "Expected Notional Value 2022" } } }, "localname": "ExpectedNotionalValueTwoThousandTwentyTwoMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsParentheticalDetails" ], "xbrltype": "domainItemType" }, "ocdx_FifthAmendmentOfCreditAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fifth amendment of credit agreement.", "label": "Fifth Amendment Of Credit Agreement [Member]", "terseLabel": "Fifth Amendment of Credit Agreement" } } }, "localname": "FifthAmendmentOfCreditAgreementMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_FirstLienNetLeverageRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First lien net leverage ratio.", "label": "First Lien Net Leverage Ratio", "terseLabel": "First lien net leverage ratio" } } }, "localname": "FirstLienNetLeverageRatio", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "pureItemType" }, "ocdx_ForeignCurrencyDenominatedDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign-currency denominated debt.", "label": "Foreign Currency Denominated Debt [Member]", "terseLabel": "Foreign-currency Denominated Debt" } } }, "localname": "ForeignCurrencyDenominatedDebtMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails" ], "xbrltype": "domainItemType" }, "ocdx_GainLossOnCrossCurrencySwapsDerivativeInstrumentsNotDesignatedAsHedgingInstruments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain (loss) on cross currency swaps derivative instruments not designated as hedging instruments.", "label": "Gain Loss On Cross Currency Swaps Derivative Instruments Not Designated As Hedging Instruments", "terseLabel": "Cross-currency interest rate swap contracts" } } }, "localname": "GainLossOnCrossCurrencySwapsDerivativeInstrumentsNotDesignatedAsHedgingInstruments", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfMarkToMarketGainsAndLossesOnNonDesignatedDerivativesRecognizedDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_GeneralAndDescriptionOfBusinessLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "General and description of business.", "label": "General And Description Of Business [Line Items]", "terseLabel": "General And Description Of Business [Line Items]" } } }, "localname": "GeneralAndDescriptionOfBusinessLineItems", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "ocdx_GeneralAndDescriptionOfBusinessTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "General and description of business.", "label": "General And Description Of Business [Table]", "terseLabel": "General And Description Of Business [Table]" } } }, "localname": "GeneralAndDescriptionOfBusinessTable", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "ocdx_GreaterChinaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Greater China.", "label": "Greater China [Member]", "terseLabel": "Greater China" } } }, "localname": "GreaterChinaMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail" ], "xbrltype": "domainItemType" }, "ocdx_GrifolsDiagnosticSolutionsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Grifols diagnostic solutions, Inc.", "label": "Grifols Diagnostic Solutions Inc [Member]", "terseLabel": "Grifols Diagnostic Solutions, Inc." } } }, "localname": "GrifolsDiagnosticSolutionsIncMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_HealthcareEquipmentCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Healthcare equipment company.", "label": "Healthcare Equipment Company [Member]", "terseLabel": "Healthcare Equipment Company" } } }, "localname": "HealthcareEquipmentCompanyMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_IncomeTaxLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income tax.", "label": "Income Tax [Line Items]", "terseLabel": "Income Tax [Line Items]" } } }, "localname": "IncomeTaxLineItems", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "ocdx_IncomeTaxTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income tax.", "label": "Income Tax [Table]", "terseLabel": "Income Tax [Table]" } } }, "localname": "IncomeTaxTable", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "ocdx_IncreaseDecreaseInAllowanceForCreditLosses": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10210.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in allowance for credit losses.", "label": "Increase Decrease In Allowance For Credit Losses", "terseLabel": "Change in allowance for credit losses" } } }, "localname": "IncreaseDecreaseInAllowanceForCreditLosses", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ocdx_IncreaseDecreaseInOtherCurrentAndNonCurrentAssets": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10250.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in other current and non-current assets.", "label": "Increase Decrease In Other Current And Non Current Assets", "negatedLabel": "Other current and non-current assets" } } }, "localname": "IncreaseDecreaseInOtherCurrentAndNonCurrentAssets", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ocdx_IncreaseDecreaseInOtherCurrentAndNonCurrentLiabilities": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10280.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in other current and non-current liabilities.", "label": "Increase Decrease In Other Current And Non Current Liabilities", "terseLabel": "Other current and non-current liabilities" } } }, "localname": "IncreaseDecreaseInOtherCurrentAndNonCurrentLiabilities", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ocdx_IndemnificationReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Indemnification receivable.", "label": "Indemnification Receivable", "terseLabel": "Indemnification receivable" } } }, "localname": "IndemnificationReceivable", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_InterestExpenseDebtNetTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest expense debt, net.", "label": "Interest Expense Debt Net Table [Text Block]", "terseLabel": "Schedule of Interest Expense, Net" } } }, "localname": "InterestExpenseDebtNetTableTextBlock", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsTables" ], "xbrltype": "textBlockItemType" }, "ocdx_InterestRateDerivativeAgreementsEffectiveDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate derivative agreements effective date.", "label": "Interest Rate Derivative Agreements Effective Date", "terseLabel": "Effective date" } } }, "localname": "InterestRateDerivativeAgreementsEffectiveDate", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails" ], "xbrltype": "dateItemType" }, "ocdx_InterestRateDerivativeAgreementsExpirationDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate derivative agreements expiration date.", "label": "Interest Rate Derivative Agreements Expiration Date", "terseLabel": "Expiration date" } } }, "localname": "InterestRateDerivativeAgreementsExpirationDate", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails" ], "xbrltype": "dateItemType" }, "ocdx_InterestRateSwap1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate swap 1.", "label": "Interest Rate Swap1 [Member]", "terseLabel": "Interest Rate Swap 1" } } }, "localname": "InterestRateSwap1Member", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails" ], "xbrltype": "domainItemType" }, "ocdx_InterestRateSwapPreviouslyHedgedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate swap previously hedged.", "label": "Interest Rate Swap Previously Hedged [Member]", "terseLabel": "Interest Rate Swap Previously Hedged" } } }, "localname": "InterestRateSwapPreviouslyHedgedMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_InventoriesAcquired": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Inventories acquired.", "label": "Inventories Acquired", "terseLabel": "Inventories, purchased", "verboseLabel": "Inventories, purchased" } } }, "localname": "InventoriesAcquired", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_JapaneseYenCrossCurrencySwapMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Japanese Yen Cross Currency Swap.", "label": "Japanese Yen Cross Currency Swap [Member]", "terseLabel": "Japanese Yen Cross Currency Swap" } } }, "localname": "JapaneseYenCrossCurrencySwapMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_JohnsonAndJohnsonMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Johnson and Johnson.", "label": "Johnson And Johnson [Member]", "terseLabel": "Johnson and Johnson" } } }, "localname": "JohnsonAndJohnsonMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_JointBusinessMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Joint business.", "label": "Joint Business [Member]", "terseLabel": "Joint Business" } } }, "localname": "JointBusinessMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_LetterAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Letter agreement.", "label": "Letter Agreement [Member]", "terseLabel": "Letter Agreement" } } }, "localname": "LetterAgreementMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_LondonInterbankOfferedFloorRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "LIBOR floor rate.", "label": "London Interbank Offered Floor Rate [Member]", "terseLabel": "LIBOR Floor Rate" } } }, "localname": "LondonInterbankOfferedFloorRateMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails": { "order": 10060.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long term debt maturities repayments of principal after year four.", "label": "Long Term Debt Maturities Repayments Of Principal After Year Four", "terseLabel": "Thereafter" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_ManagementFeeAndOtherOutOfPocketExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Management fee and other out-of-pocket expenses.", "label": "Management Fee And Other Out Of Pocket Expenses", "terseLabel": "Management fee and other out-of-pocket expenses" } } }, "localname": "ManagementFeeAndOtherOutOfPocketExpenses", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_MaximumAmountOfReceivableToBeSold": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum amount of receivable to be sold.", "label": "Maximum Amount Of Receivable To Be Sold", "terseLabel": "Maximum amount of receivable to be sold" } } }, "localname": "MaximumAmountOfReceivableToBeSold", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_MaximumPercentageOfCommittedAmountForFirstLienNetLeverageRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum percentage of committed amount for first lien net leverage ratio.", "label": "Maximum Percentage Of Committed Amount For First Lien Net Leverage Ratio", "terseLabel": "Maximum percentage of committed amount for first lien net leverage ratio" } } }, "localname": "MaximumPercentageOfCommittedAmountForFirstLienNetLeverageRatio", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_MilestonePaymentsAndOtherNet": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10130.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Milestone payments and other, net.", "label": "Milestone Payments And Other Net", "terseLabel": "Milestone payments and other, net" } } }, "localname": "MilestonePaymentsAndOtherNet", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ocdx_MinimumReagentPurchasesLeaseTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum reagent purchases lease term.", "label": "Minimum Reagent Purchases Lease Term", "terseLabel": "Minimum reagent purchases over lease term" } } }, "localname": "MinimumReagentPurchasesLeaseTerm", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "ocdx_NetProfitSharedUnderJointVentureBeforeTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net profit shared under joint venture, before tax.", "label": "Net Profit Shared Under Joint Venture Before Tax", "terseLabel": "Net profit shared under joint venture, before tax" } } }, "localname": "NetProfitSharedUnderJointVentureBeforeTax", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_NonRefundableUpfrontPayment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non-refundable upfront payment.", "label": "Non Refundable Upfront Payment", "terseLabel": "Non-refundable upfront payment" } } }, "localname": "NonRefundableUpfrontPayment", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_NoncashInvestingAndFinancingActivitiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Noncash investing and financing activities.", "label": "Noncash Investing And Financing Activities [Text Block]", "terseLabel": "Noncash Investing and Financing Activities" } } }, "localname": "NoncashInvestingAndFinancingActivitiesTextBlock", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureNoncashInvestingAndFinancingActivities" ], "xbrltype": "textBlockItemType" }, "ocdx_NoncashTransferOfInventoryToPropertyPlantAndEquipment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Noncash transfer of inventory to property, plant and equipment.", "label": "Noncash Transfer Of Inventory To Property Plant And Equipment", "terseLabel": "Noncash transfer of inventory to property, plant and equipment, net" } } }, "localname": "NoncashTransferOfInventoryToPropertyPlantAndEquipment", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureNoncashInvestingAndFinancingActivitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_NumberOfAwardsUnderCollaborationAndLicenseAgreements": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of awards under collaboration and license agreements.", "label": "Number Of Awards Under Collaboration And License Agreements", "terseLabel": "Number of awards under collaboration and license agreements" } } }, "localname": "NumberOfAwardsUnderCollaborationAndLicenseAgreements", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "ocdx_NumberOfCollaborationAndLicenseAgreements": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of collaboration and license agreements.", "label": "Number Of Collaboration And License Agreements", "terseLabel": "Number of collaboration and license agreements" } } }, "localname": "NumberOfCollaborationAndLicenseAgreements", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "ocdx_NumberOfCountriesAndTerritoriesWithCommercialPresence": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of countries and territories with commercial presence.", "label": "Number Of Countries And Territories With Commercial Presence", "terseLabel": "Number of countries and territories with commercial presence" } } }, "localname": "NumberOfCountriesAndTerritoriesWithCommercialPresence", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "ocdx_NumberOfCountriesWithDirectCommercialPresence": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of countries with direct commercial presence.", "label": "Number Of Countries With Direct Commercial Presence", "terseLabel": "Number of countries with direct commercial presence" } } }, "localname": "NumberOfCountriesWithDirectCommercialPresence", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "ocdx_OfferingExpensesIncludedInAccountsPayableAndAccruedLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Offering expenses included in accounts payable and accrued liabilities.", "label": "Offering Expenses Included In Accounts Payable And Accrued Liabilities", "terseLabel": "Initial public offering costs included in Accounts payable and Accrued liabilities" } } }, "localname": "OfferingExpensesIncludedInAccountsPayableAndAccruedLiabilities", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureNoncashInvestingAndFinancingActivitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_OrthoClinicalDiagnosticsHoldingLuxembourgSRLMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ortho-Clinical Diagnostics Holdings Luxembourg S.\u00e0 r.l.", "label": "Ortho Clinical Diagnostics Holding Luxembourg S R L [Member]", "terseLabel": "Ortho-Clinical Diagnostics Holdings Luxembourg S.\u00e0 r.l" } } }, "localname": "OrthoClinicalDiagnosticsHoldingLuxembourgSRLMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_OrthoClinicalDiagnosticsSAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ortho-Clinical Diagnostics S.A.", "label": "Ortho Clinical Diagnostics S A [Member]", "terseLabel": "Ortho-Clinical Diagnostics S.A." } } }, "localname": "OrthoClinicalDiagnosticsSAMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_OtherAdjustments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other adjustments.", "label": "Other Adjustments", "terseLabel": "Other adjustments" } } }, "localname": "OtherAdjustments", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationReconciliationOfNetLossToAdjustedEBITDADetail" ], "xbrltype": "monetaryItemType" }, "ocdx_OtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other.", "label": "Other [Member]", "terseLabel": "Other" } } }, "localname": "OtherMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail" ], "xbrltype": "domainItemType" }, "ocdx_PercentageOfDebtBorrowingBaseRateOnAccountReceivable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of debt borrowing base rate on account receivable.", "label": "Percentage Of Debt Borrowing Base Rate On Account Receivable", "terseLabel": "Percentage of Debt Borrowing Base Rate on Account Receivable" } } }, "localname": "PercentageOfDebtBorrowingBaseRateOnAccountReceivable", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_PharmacyRelatedServicesFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Pharmacy related services fee.", "label": "Pharmacy Related Services Fee", "terseLabel": "Pharmacy related services, fees" } } }, "localname": "PharmacyRelatedServicesFee", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_PotentialAdditionalPaymentsUponAchievementOfCertainRegulatoryMilestonesAndCommercialSalesBenchmarks": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Potential additional payments upon achievement of certain regulatory milestones and commercial sales benchmarks.", "label": "Potential Additional Payments Upon Achievement Of Certain Regulatory Milestones And Commercial Sales Benchmarks", "terseLabel": "Potential additional payments upon achievement of certain regulatory milestones and commercial sales benchmarks" } } }, "localname": "PotentialAdditionalPaymentsUponAchievementOfCertainRegulatoryMilestonesAndCommercialSalesBenchmarks", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_PotentialPaymentReceivableForDevelopmentAndSubmissionOfEmergencyUseAuthorizationsAndFiveOneZeroKApplicationsOfCOVIDNineteenTests": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Potential payment receivable for development and submission of emergency use authorizations and five one zero k applications of COVID nineteen tests.", "label": "Potential Payment Receivable For Development And Submission Of Emergency Use Authorizations And Five One Zero K Applications Of C O V I D Nineteen Tests", "terseLabel": "Potential payment receivable for development and submission of emergency use authorizations and 510(k) applications of COVID-19 tests" } } }, "localname": "PotentialPaymentReceivableForDevelopmentAndSubmissionOfEmergencyUseAuthorizationsAndFiveOneZeroKApplicationsOfCOVIDNineteenTests", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_PotentialPaymentsUponAchievementOfCertainCumulativeRevenueMilestones": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Potential payments upon achievement of certain cumulative revenue milestones.", "label": "Potential Payments Upon Achievement Of Certain Cumulative Revenue Milestones", "terseLabel": "Potential payments upon achievement of certain cumulative revenue milestones" } } }, "localname": "PotentialPaymentsUponAchievementOfCertainCumulativeRevenueMilestones", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_ProceedsFromCrossCurrencySwaps": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10120.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from cross currency swaps.", "label": "Proceeds From Cross Currency Swaps", "terseLabel": "Proceeds from cross currency swaps" } } }, "localname": "ProceedsFromCrossCurrencySwaps", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ocdx_PurchasesOfPropertyPlantAndEquipmentAndCapitalizedInternalUseSoftwareCostsIncludedInAccountsPayableAndAccruedLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Purchases of property, plant and equipment and capitalized internal-use software costs included in accounts payable and accrued liabilities.", "label": "Purchases Of Property Plant And Equipment And Capitalized Internal Use Software Costs Included In Accounts Payable And Accrued Liabilities", "terseLabel": "Purchases of property, plant and equipment and capitalized internal-use software costs included in Accounts payable and Accrued liabilities" } } }, "localname": "PurchasesOfPropertyPlantAndEquipmentAndCapitalizedInternalUseSoftwareCostsIncludedInAccountsPayableAndAccruedLiabilities", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureNoncashInvestingAndFinancingActivitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_QuotientLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Quotient limited.", "label": "Quotient Limited [Member]", "terseLabel": "Quotient Limited" } } }, "localname": "QuotientLimitedMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_ReceivablesPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Receivables purchase agreement.", "label": "Receivables Purchase Agreement [Member]", "terseLabel": "Receivables Purchase Agreement" } } }, "localname": "ReceivablesPurchaseAgreementMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_RedemptionOptionPercentageOfPrincipalAmountOfDebtWithNetCashProceedsOfEquityOfferings": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption option percentage of principal amount of debt with net cash proceeds of equity offerings.", "label": "Redemption Option Percentage Of Principal Amount Of Debt With Net Cash Proceeds Of Equity Offerings", "terseLabel": "Percentage of principal amount of debt with net cash proceeds of equity offerings" } } }, "localname": "RedemptionOptionPercentageOfPrincipalAmountOfDebtWithNetCashProceedsOfEquityOfferings", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_ReportableSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reportable Segment.", "label": "Reportable Segment [Member]", "terseLabel": "Reportable Segment" } } }, "localname": "ReportableSegmentMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail" ], "xbrltype": "domainItemType" }, "ocdx_SaleAndLeasebackFinancingArrangementPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale and leaseback financing arrangement period.", "label": "Sale And Leaseback Financing Arrangement Period", "terseLabel": "Financing period" } } }, "localname": "SaleAndLeasebackFinancingArrangementPeriod", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSaleAndLeasebackFinancingAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "ocdx_SaleAndLeasebackFinancingAssetsSold": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sale and leaseback financing assets sold.", "label": "Sale And Leaseback Financing Assets Sold", "terseLabel": "Property and equipment sold under sale and leaseback financing" } } }, "localname": "SaleAndLeasebackFinancingAssetsSold", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSaleAndLeasebackFinancingAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_SaleAndLeasebackFinancingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale and leaseback financing.", "label": "Sale And Leaseback Financing [Member]", "terseLabel": "Sale and Leaseback Financing" } } }, "localname": "SaleAndLeasebackFinancingMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails" ], "xbrltype": "domainItemType" }, "ocdx_SaleAndLeasebackFinancingObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sale and leaseback financing obligation.", "label": "Sale And Leaseback Financing Obligation", "terseLabel": "Financing obligation" } } }, "localname": "SaleAndLeasebackFinancingObligation", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSaleAndLeasebackFinancingAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_ScheduleOfCashAndCashEquivalentsRestrictedCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of cash and cash equivalents, restricted cash and cash equivalents.", "label": "Schedule Of Cash And Cash Equivalents Restricted Cash And Cash Equivalents Table [Text Block]", "terseLabel": "Schedule of Cash and Cash Equivalents and Restricted Cash" } } }, "localname": "ScheduleOfCashAndCashEquivalentsRestrictedCashAndCashEquivalentsTableTextBlock", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationTables" ], "xbrltype": "textBlockItemType" }, "ocdx_ScheduleOfForeignCurrencyForwardContractsOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of foreign currency forward contracts outstanding.", "label": "Schedule Of Foreign Currency Forward Contracts Outstanding", "terseLabel": "Schedule of Currency Hedging Instruments Outstanding" } } }, "localname": "ScheduleOfForeignCurrencyForwardContractsOutstanding", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "ocdx_SeniorSecuredCreditFacilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior secured credit facilities.", "label": "Senior Secured Credit Facilities [Member]", "terseLabel": "Senior Secured Credit Facilities" } } }, "localname": "SeniorSecuredCreditFacilitiesMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_SevenPointThreeSevenFivePercentSeniorNotesDueTwoThousandTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Seven point three seven five percent senior notes due two thousand twenty five.", "label": "Seven Point Three Seven Five Percent Senior Notes Due Two Thousand Twenty Five [Member]", "terseLabel": "2025 Notes", "verboseLabel": "2025 Notes" } } }, "localname": "SevenPointThreeSevenFivePercentSeniorNotesDueTwoThousandTwentyFiveMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsTables", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFairValuesOfLongTermBorrowingsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_SevenPointTwoFiveZeroPercentSeniorNotesDueTwoThousandTwentyEightMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Seven point two five zero percent senior notes due two thousand twenty eight notes.", "label": "Seven Point Two Five Zero Percent Senior Notes Due Two Thousand Twenty Eight [Member]", "terseLabel": "2028 Notes", "verboseLabel": "2028 Notes" } } }, "localname": "SevenPointTwoFiveZeroPercentSeniorNotesDueTwoThousandTwentyEightMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsTables", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFairValuesOfLongTermBorrowingsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingRightsPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award award remaining vesting rights percentage.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Remaining Vesting Rights Percentage", "terseLabel": "Remaining percentage of vesting award" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingRightsPercentage", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "ocdx_SixPointSixTwoFivePercentSeniorNotesDueTwoThousandTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Six point six two five percent senior notes due two thousand twenty two.", "label": "Six Point Six Two Five Percent Senior Notes Due Two Thousand Twenty Two [Member]", "terseLabel": "2022 Notes" } } }, "localname": "SixPointSixTwoFivePercentSeniorNotesDueTwoThousandTwentyTwoMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2022NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails" ], "xbrltype": "domainItemType" }, "ocdx_SummaryOfSignificantAccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of significant accounting policies.", "label": "Summary Of Significant Accounting Policies [Line Items]", "terseLabel": "Summary Of Significant Accounting Policies [Line Items]" } } }, "localname": "SummaryOfSignificantAccountingPoliciesLineItems", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRecentAccountingPronouncementsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "ocdx_SummaryOfSignificantAccountingPoliciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of significant accounting policies.", "label": "Summary Of Significant Accounting Policies [Table]", "terseLabel": "Summary Of Significant Accounting Policies [Table]" } } }, "localname": "SummaryOfSignificantAccountingPoliciesTable", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRecentAccountingPronouncementsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "ocdx_SupplementalBalanceSheetInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Supplemental balance sheet information.", "label": "Supplemental Balance Sheet Information [Abstract]" } } }, "localname": "SupplementalBalanceSheetInformationAbstract", "nsuri": "http://orthoclinical.com/20210704", "xbrltype": "stringItemType" }, "ocdx_TaxIndemnificationIncomeNet": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited": { "order": 10050.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Tax indemnification income, net.", "label": "Tax Indemnification Income Net", "negatedLabel": "Tax indemnification income, net" } } }, "localname": "TaxIndemnificationIncomeNet", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationReconciliationOfNetLossToAdjustedEBITDADetail", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "ocdx_TechnologyServicesFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Technology services fee..", "label": "Technology Services Fee", "terseLabel": "IT service fees" } } }, "localname": "TechnologyServicesFee", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "ocdx_TransfusionMedicineMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transfusion medicine.", "label": "Transfusion Medicine [Member]", "terseLabel": "Transfusion Medicine" } } }, "localname": "TransfusionMedicineMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails" ], "xbrltype": "domainItemType" }, "ocdx_UKHoldcoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "UK Holdco.", "label": "U K Holdco [Member]", "terseLabel": "UK Holdco" } } }, "localname": "UKHoldcoMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "ocdx_UnrealizedForeignCurrencyTransactionGainLossRemeasurement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Unrealized foreign currency transaction gain loss remeasurement.", "label": "Unrealized Foreign Currency Transaction Gain Loss Remeasurement", "negatedLabel": "Unrealized foreign currency exchanges losses, net" } } }, "localname": "UnrealizedForeignCurrencyTransactionGainLossRemeasurement", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationReconciliationOfNetLossToAdjustedEBITDADetail" ], "xbrltype": "monetaryItemType" }, "ocdx_UnvestedRestrictedSharesAndRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unvested restricted shares and restricted stock units.", "label": "Unvested Restricted Shares And Restricted Stock Units [Member]", "terseLabel": "Unvested restricted shares and restricted stock units" } } }, "localname": "UnvestedRestrictedSharesAndRestrictedStockUnitsMember", "nsuri": "http://orthoclinical.com/20210704", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureNetLossPerShareSummaryOfPotentialGrossOrdinarySharesEquivalentExcludedFromComputationOfNetLossPerShareDetails" ], "xbrltype": "domainItemType" }, "srt_AmericasMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Americas [Member]", "terseLabel": "Americas" } } }, "localname": "AmericasMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r150", "r163", "r164", "r165", "r166", "r168", "r170", "r174" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r150", "r163", "r164", "r165", "r166", "r168", "r170", "r174" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r56", "r109" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r295", "r297", "r454", "r455", "r456", "r457", "r458", "r459", "r478", "r530", "r533" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum", "verboseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r295", "r297", "r454", "r455", "r456", "r457", "r458", "r459", "r478", "r530", "r533" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Axis]", "terseLabel": "Ownership" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Domain]", "terseLabel": "Ownership" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r177", "r266", "r270", "r479", "r529", "r531" ], "lang": { "en-us": { "role": { "label": "Product Or Service [Axis]", "terseLabel": "Product and Service" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r177", "r266", "r270", "r479", "r529", "r531" ], "lang": { "en-us": { "role": { "label": "Products And Services [Domain]", "terseLabel": "Product and Service" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r285", "r295", "r297", "r454", "r455", "r456", "r457", "r458", "r459", "r478", "r530", "r533" ], "lang": { "en-us": { "role": { "label": "Range [Axis]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r285", "r295", "r297", "r454", "r455", "r456", "r457", "r458", "r459", "r478", "r530", "r533" ], "lang": { "en-us": { "role": { "label": "Range [Member]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Repurchase Agreement Counterparty Name [Domain]", "terseLabel": "Counterparty Name" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "label": "Scenario Forecast [Member]", "terseLabel": "Scenario Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r296" ], "lang": { "en-us": { "role": { "label": "Scenario Unspecified [Domain]", "terseLabel": "Scenario" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r178", "r179", "r266", "r271", "r532", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556" ], "lang": { "en-us": { "role": { "label": "Segment Geographical [Domain]", "terseLabel": "Geographical" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r178", "r179", "r266", "r271", "r532", "r547", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557" ], "lang": { "en-us": { "role": { "label": "Statement Geographical [Axis]", "terseLabel": "Geographical" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r232", "r296", "r447" ], "lang": { "en-us": { "role": { "label": "Statement Scenario [Axis]", "terseLabel": "Scenario" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201912Member": { "auth_ref": [ "r341", "r342", "r343", "r344" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2019-12 Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.", "label": "Accounting Standards Update201912 [Member]", "terseLabel": "ASU 2019-12" } } }, "localname": "AccountingStandardsUpdate201912Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRecentAccountingPronouncementsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r36" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10140.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r5", "r21", "r184", "r185" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10250.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable Net Current", "terseLabel": "Accounts receivable (net of allowance for credit losses of $9.7 and $9.8, respectively)" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent": { "auth_ref": [ "r10", "r40", "r325" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfAccruedLiabilitiesDetails": { "order": 10050.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrual For Taxes Other Than Income Taxes Current", "terseLabel": "Accrued taxes other than income" } } }, "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r16", "r501", "r516" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfAccruedLiabilitiesDetails": { "order": 10070.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes Current", "terseLabel": "Income taxes payable" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r40" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfAccruedLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10150.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities Current", "terseLabel": "Accrued liabilities", "totalLabel": "Total accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfAccruedLiabilitiesDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r61", "r66", "r67", "r371" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment [Member]", "terseLabel": "Pension and Other Postemployment Benefits" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "auth_ref": [ "r66", "r74", "r370" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.", "label": "Accumulated Gain Loss Net Cash Flow Hedge Parent [Member]", "terseLabel": "Derivatives" } } }, "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income Loss [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income Loss [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r24", "r63", "r65", "r66", "r518", "r541", "r545" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10080.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income Loss Net Of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r422", "r423", "r424", "r425", "r426", "r428" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income Loss [Table]", "terseLabel": "Accumulated Other Comprehensive Income Loss [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r62", "r66", "r67", "r115", "r116", "r117", "r371", "r536", "r537" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "Accumulated Other Comprehensive Income [Member]", "terseLabel": "Accumulated Other Comprehensive Loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r59", "r66", "r67", "r371", "r423", "r424", "r425", "r426", "r428" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Translation Adjustment [Member]", "terseLabel": "Unrealized Foreign Currency Translation Adjustments" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r22", "r320" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10060.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid In Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r115", "r116", "r117", "r316", "r317", "r318" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid In Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r120", "r121", "r122", "r124", "r195", "r196", "r197", "r198", "r201", "r202", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r320", "r341", "r342", "r343", "r344", "r480", "r481", "r482", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Adjustments For New Accounting Pronouncements [Axis]", "terseLabel": "Accounting Standards Update" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRecentAccountingPronouncementsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r298", "r300", "r322", "r323" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value", "terseLabel": "Recognition of stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": { "auth_ref": [ "r245", "r250" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.", "label": "Adjustments To Additional Paid In Capital Stock Issued Issuance Costs", "terseLabel": "Adjustments of offering costs related to initial public offering" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to cash provided by (used in) operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r300", "r308", "r321" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Allocated Share Based Compensation Expense", "terseLabel": "Total stock-based compensation" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockBasedCompensationUnderStatementsOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r28", "r186", "r203" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Allowance For Doubtful Accounts Receivable Current", "terseLabel": "Allowance for credit losses" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r86", "r102", "r430" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails": { "order": 10090.0, "parentTag": "us-gaap_InterestExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization Of Debt Discount Premium", "terseLabel": "Original issue discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r83", "r102", "r432" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails": { "order": 10080.0, "parentTag": "us-gaap_InterestExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization Of Financing Costs", "terseLabel": "Deferred financing costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r102", "r432" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10180.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization Of Financing Costs And Discounts", "terseLabel": "Amortization of deferred financing costs and original issue discount" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscountsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Amortization Of Financing Costs And Discounts [Abstract]", "terseLabel": "Amortization of:" } } }, "localname": "AmortizationOfFinancingCostsAndDiscountsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r102", "r219", "r221" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited": { "order": 10100.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization Of Intangible Assets", "terseLabel": "Amortization of intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount", "terseLabel": "Antidilutive securities excluded from computation of net loss per share" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureNetLossPerShareSummaryOfPotentialGrossOrdinarySharesEquivalentExcludedFromComputationOfNetLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureNetLossPerShareSummaryOfPotentialGrossOrdinarySharesEquivalentExcludedFromComputationOfNetLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureNetLossPerShareSummaryOfPotentialGrossOrdinarySharesEquivalentExcludedFromComputationOfNetLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities Name [Domain]", "terseLabel": "Antidilutive Securities, Name" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureNetLossPerShareSummaryOfPotentialGrossOrdinarySharesEquivalentExcludedFromComputationOfNetLossPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": { "auth_ref": [ "r63" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax", "terseLabel": "Derivative loss included in AOCI" } } }, "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Arrangements And Nonarrangement Transactions [Member]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r106", "r158", "r165", "r172", "r191", "r366", "r372", "r415", "r500", "r515" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r6", "r7", "r54", "r106", "r191", "r366", "r372", "r415" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10180.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r301", "r310" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueScheduleOfBalanceOfContractAssetsRecordedInConsolidatedBalanceSheetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r384", "r388" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueScheduleOfBalanceOfContractAssetsRecordedInConsolidatedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BaseRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum rate investor will accept.", "label": "Base Rate [Member]", "terseLabel": "Base Rate" } } }, "localname": "BaseRateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r2", "r114", "r144" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Business Description And Basis Of Presentation [Text Block]", "terseLabel": "Basis of Presentation of the Unaudited Consolidated Financial Statements" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBasisOfPresentationOfUnauditedConsolidatedFinancialStatements" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r33", "r104" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfCashAndCashEquivalentsAndRestrictedCashDetails": { "order": 10010.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "weight": 1.0 }, "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10240.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash And Cash Equivalents At Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfCashAndCashEquivalentsAndRestrictedCashDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r98", "r104", "r105" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfCashAndCashEquivalentsAndRestrictedCashDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period", "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period", "totalLabel": "Cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfCashAndCashEquivalentsAndRestrictedCashDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r98", "r421" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect", "totalLabel": "Increase (decrease) in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r380" ], "lang": { "en-us": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash Flow Hedge" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueExcludingAmortizationOfIntangibleAssetsInStatementsOfOperationsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIParentheticalDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted": { "auth_ref": [ "r118", "r192", "r193", "r194", "r195", "r196", "r312", "r313", "r314", "r341", "r404", "r416", "r435", "r480", "r481", "r534", "r535" ], "lang": { "en-us": { "role": { "documentation": "Indicates (true false) whether accounting standards update was adopted.", "label": "Change In Accounting Principle Accounting Standards Update Adopted", "terseLabel": "Change in accounting principle, accounting standards update, adopted [true false]" } } }, "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRecentAccountingPronouncementsAdditionalInformationDetails" ], "xbrltype": "booleanItemType" }, "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate": { "auth_ref": [ "r127", "r192", "r193", "r194", "r195", "r196", "r312", "r313", "r314", "r341", "r404", "r416", "r435", "r480", "r481", "r534", "r535" ], "lang": { "en-us": { "role": { "documentation": "Date accounting standards update was adopted, in CCYY-MM-DD format.", "label": "Change In Accounting Principle Accounting Standards Update Adoption Date", "terseLabel": "Change in accounting principle, accounting standards update, adoption date" } } }, "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRecentAccountingPronouncementsAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect": { "auth_ref": [ "r120", "r132", "r199", "r320", "r347" ], "lang": { "en-us": { "role": { "documentation": "Indicates (true false) whether effect from applying amendment to accounting standards is immaterial.", "label": "Change In Accounting Principle Accounting Standards Update Immaterial Effect", "terseLabel": "Change in accounting principle, accounting standards update, immaterial effect [true false]" } } }, "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRecentAccountingPronouncementsAdditionalInformationDetails" ], "xbrltype": "booleanItemType" }, "us-gaap_CollaborativeArrangementDisclosureTextBlock": { "auth_ref": [ "r360", "r361", "r363" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.", "label": "Collaborative Arrangement Disclosure [Text Block]", "terseLabel": "Collaborations and other relationships" } } }, "localname": "CollaborativeArrangementDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCollaborationsAndOtherRelationships" ], "xbrltype": "textBlockItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]", "terseLabel": "Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r46", "r231", "r505", "r522" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10020.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments And Contingencies", "terseLabel": "Commitments and contingencies (Note 15)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments And Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r228", "r229", "r230", "r233" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments And Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r115", "r116" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock", "verboseLabel": "Ordinary Shares" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock Par Or Stated Value Per Share", "terseLabel": "Ordinary shares, value per share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock Shares Authorized", "terseLabel": "Ordinary shares, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock Shares Issued", "terseLabel": "Ordinary shares, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r20", "r245" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock Shares Outstanding", "terseLabel": "Ordinary shares, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r20" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10050.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock Value", "terseLabel": "Ordinary shares, $0.00001 par, 1,000,000,000 shares authorized, 234,921,002 and 147,295,511 shares issued and outstanding as of July 4, 2021 and January 3, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r70", "r72", "r73", "r82", "r509", "r526" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income Net Of Tax", "totalLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r81", "r88", "r508", "r525" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income Note [Text Block]", "terseLabel": "Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLoss" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r256" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.", "label": "Contract With Customer Asset And Liability Table [Text Block]", "terseLabel": "Schedule of Balance of Contract Assets Recorded in Consolidated Balance Sheets" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetCreditLossExpense": { "auth_ref": [ "r205", "r255", "r265" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Contract With Customer Asset Credit Loss Expense", "terseLabel": "Credit losses related to contract assets" } } }, "localname": "ContractWithCustomerAssetCreditLossExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerAssetNet": { "auth_ref": [ "r252", "r254", "r267" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Contract With Customer Asset Net", "terseLabel": "Contract asset", "verboseLabel": "Total contract assets" } } }, "localname": "ContractWithCustomerAssetNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueScheduleOfBalanceOfContractAssetsRecordedInConsolidatedBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r252", "r253", "r267" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract With Customer Liability Current", "terseLabel": "Deferred revenue, current" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [ "r252", "r253", "r267" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Contract With Customer Liability Noncurrent", "terseLabel": "Deferred revenue, non-current" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r268" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract With Customer Liability Revenue Recognized", "terseLabel": "Deferred revenue, revenue recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r163", "r164", "r165", "r166", "r168", "r174", "r176" ], "lang": { "en-us": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate Non Segment [Member]", "terseLabel": "Corporate" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization": { "auth_ref": [ "r78", "r79" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited": { "order": 10130.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost of product sold and service rendered, excluding depreciation, depletion, and amortization.", "label": "Cost Of Goods And Service Excluding Depreciation Depletion And Amortization", "terseLabel": "Cost of revenue, excluding amortization of intangible assets" } } }, "localname": "CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueExcludingAmortizationOfIntangibleAssetsInStatementsOfOperationsDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost Of Sales [Member]", "terseLabel": "Cost of revenue" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockBasedCompensationUnderStatementsOfOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFairValuesOfLongTermBorrowingsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFairValuesOfLongTermBorrowingsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CrossCurrencyInterestRateContractMember": { "auth_ref": [ "r286", "r396" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.", "label": "Cross Currency Interest Rate Contract [Member]", "terseLabel": "U.S. Dollar to Japanese Yen Cross Currency Swaps" } } }, "localname": "CrossCurrencyInterestRateContractMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtAndCapitalLeaseObligations": { "auth_ref": [ "r504", "r523" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term and long-term debt and lease obligation.", "label": "Debt And Capital Lease Obligations", "totalLabel": "Total borrowings" } } }, "localname": "DebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtCurrent": { "auth_ref": [ "r38" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails2": { "order": 10010.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0 }, "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10170.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.", "label": "Debt Current", "negatedLabel": "Less: Current portion", "terseLabel": "Current portion of borrowings" } } }, "localname": "DebtCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Borrowings and Other Arrangements" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument Basis Spread On Variable Rate1", "terseLabel": "Debt instrument, variable percentage rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r17", "r238", "r502", "r514" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails": { "order": 10010.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Debt Instrument Carrying Amount", "terseLabel": "Long-term borrowings, gross", "verboseLabel": "Long-term borrowings, outstanding balance" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2022NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r431", "r433" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument Face Amount", "positiveVerboseLabel": "Debt borrowing amount", "terseLabel": "Aggregate principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r42", "r240", "r431" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument Interest Rate Effective Percentage", "terseLabel": "Debt instrument, effective interest rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument Interest Rate Stated Percentage", "terseLabel": "Debt instrument, stated interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2022NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2022NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsTables" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r43", "r411" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.", "label": "Debt Instrument Maturity Date", "terseLabel": "Debt instrument, maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentMaturityDateDescription": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.", "label": "Debt Instrument Maturity Date Description", "terseLabel": "Debt instrument, maturity date, description" } } }, "localname": "DebtInstrumentMaturityDateDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodAxis": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "Information about timing of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument Redemption Period [Axis]", "terseLabel": "Debt Instrument, Redemption, Period" } } }, "localname": "DebtInstrumentRedemptionPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodDomain": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "Period as defined under terms of the debt agreement for debt redemption features.", "label": "Debt Instrument Redemption Period [Domain]", "terseLabel": "Debt Instrument, Redemption, Period" } } }, "localname": "DebtInstrumentRedemptionPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodFiveMember": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "Period five representing fifth most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument Redemption Period Five [Member]", "terseLabel": "2025 and Thereafter" } } }, "localname": "DebtInstrumentRedemptionPeriodFiveMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodFourMember": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "Period four representing fourth most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument Redemption Period Four [Member]", "terseLabel": "2024" } } }, "localname": "DebtInstrumentRedemptionPeriodFourMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodOneMember": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument Redemption Period One [Member]", "terseLabel": "2022" } } }, "localname": "DebtInstrumentRedemptionPeriodOneMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodStartDate": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "Start date of debt instrument redemption period, in CCYY-MM-DD format.", "label": "Debt Instrument Redemption Period Start Date", "terseLabel": "Debt instrument, redemption period start date" } } }, "localname": "DebtInstrumentRedemptionPeriodStartDate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument Redemption Period Three [Member]", "terseLabel": "2024 and Thereafter" } } }, "localname": "DebtInstrumentRedemptionPeriodThreeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument Redemption Period Two [Member]", "terseLabel": "2023" } } }, "localname": "DebtInstrumentRedemptionPeriodTwoMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument Redemption Price Percentage", "terseLabel": "Redemption price percentage" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentRedemptionTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of debt instruments or arrangements with redemption features. Includes, but is not limited to, description of debt redemption features, percentage price at which debt can be redeemed by the issuer, and period start and end for debt maturity or redemption.", "label": "Debt Instrument Redemption Table [Text Block]", "terseLabel": "Schedule of Redemption Prices Expressed as Percentages of Principal Amount" } } }, "localname": "DebtInstrumentRedemptionTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r44", "r110", "r246", "r247", "r248", "r249", "r430", "r431", "r433", "r513" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Debt Instrument [Table]", "terseLabel": "Debt Instrument [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2022NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsTables" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r430", "r433" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails": { "order": 10120.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument Unamortized Discount", "negatedLabel": "Unamortized original issue discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsGross": { "auth_ref": [ "r432" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Deferred Finance Costs Gross", "terseLabel": "Deferred financing costs, gross" } } }, "localname": "DeferredFinanceCostsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r34", "r432" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails": { "order": 10110.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Deferred Finance Costs Net", "negatedLabel": "Unamortized deferred financing costs", "terseLabel": "Unamortized deferred financing costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r330", "r331" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10220.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets Net", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r102", "r107", "r340", "r350", "r351", "r352" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10200.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense Benefit", "terseLabel": "Deferred tax provision (benefit)" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r330", "r331" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10130.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities Net", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r29" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10160.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue Current", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r102", "r222" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10150.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation And Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r102", "r153" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation Depletion And Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationReconciliationOfNetLossToAdjustedEBITDADetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAverageFixedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average fixed interest rate related to the group of interest rate derivatives.", "label": "Derivative Average Fixed Interest Rate", "terseLabel": "Weighted average interest rate" } } }, "localname": "DerivativeAverageFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeCapInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cap rate on an interest rate derivative such as an interest rate cap or collar. If market rates exceed the cap rate, a payment or receipt is triggered on the contract.", "label": "Derivative Cap Interest Rate", "terseLabel": "Interest rate cap amount" } } }, "localname": "DerivativeCapInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract Type [Domain]", "terseLabel": "Derivative Contract" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueExcludingAmortizationOfIntangibleAssetsInStatementsOfOperationsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIParentheticalDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsParentheticalDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnauditedParenthetical", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r385", "r387", "r394", "r398" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument Risk [Axis]", "terseLabel": "Derivative Instrument" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueExcludingAmortizationOfIntangibleAssetsInStatementsOfOperationsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIParentheticalDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsParentheticalDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnauditedParenthetical", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments And Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r408" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments And Hedging Activities Disclosure [Text Block]", "terseLabel": "Derivative Instruments and Hedging Activities" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivities" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r382", "r385", "r394" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Derivative Instruments Gain Loss By Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueExcludingAmortizationOfIntangibleAssetsInStatementsOfOperationsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIParentheticalDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred": { "auth_ref": [ "r407" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings.", "label": "Derivative Instruments Gain Loss Reclassification From Accumulated O C I To Income Estimated Net Amount To Be Transferred", "terseLabel": "Amount reclassified from AOCI into income due to forecast transaction that is no longer probable of occurring" } } }, "localname": "DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueExcludingAmortizationOfIntangibleAssetsInStatementsOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": { "auth_ref": [ "r391", "r397" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.", "label": "Derivative Instruments Gain Loss Reclassified From Accumulated O C I Into Income Effective Portion Net", "terseLabel": "Amount of loss (gain) reclassified from AOCI into income" } } }, "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueExcludingAmortizationOfIntangibleAssetsInStatementsOfOperationsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r55" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfAccruedLiabilitiesDetails": { "order": 10020.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liabilities Current", "terseLabel": "Derivatives" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueExcludingAmortizationOfIntangibleAssetsInStatementsOfOperationsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIParentheticalDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsParentheticalDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfMarkToMarketGainsAndLossesOnNonDesignatedDerivativesRecognizedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r377", "r379" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative Notional Amount", "terseLabel": "Derivative notional amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeRemainingMaturity1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period remaining until the derivative contract matures, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Derivative Remaining Maturity1", "terseLabel": "Derivative instrument term" } } }, "localname": "DerivativeRemainingMaturity1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r376", "r378", "r379", "r382", "r383", "r389", "r394", "r400", "r401", "r405" ], "lang": { "en-us": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueExcludingAmortizationOfIntangibleAssetsInStatementsOfOperationsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIParentheticalDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsParentheticalDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfMarkToMarketGainsAndLossesOnNonDesignatedDerivativesRecognizedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeVariableInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.", "label": "Derivative Variable Interest Rate", "terseLabel": "Interest rate paid" } } }, "localname": "DerivativeVariableInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r382" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated As Hedging Instrument [Member]", "terseLabel": "Designated as Hedging Instrument" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueExcludingAmortizationOfIntangibleAssetsInStatementsOfOperationsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIParentheticalDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation Of Revenue [Line Items]", "terseLabel": "Disaggregation Of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueScheduleOfBalanceOfContractAssetsRecordedInConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r266", "r270", "r271", "r272", "r273", "r274", "r275", "r276" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation Of Revenue [Table]", "terseLabel": "Disaggregation Of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueScheduleOfBalanceOfContractAssetsRecordedInConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r266" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation Of Revenue Table [Text Block]", "terseLabel": "Summary of Net Revenue by Line of Business" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Disclosure Of Compensation Related Costs Share Based Payments [Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EMEAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Regions of Europe, Middle East and Africa.", "label": "E M E A [Member]", "terseLabel": "EMEA" } } }, "localname": "EMEAMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EarlyRepaymentOfSeniorDebt": { "auth_ref": [ "r93" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the extinguishment of long-term borrowing, with the highest claim on the assets of the entity in case of bankruptcy or liquidation, before its maturity.", "label": "Early Repayment Of Senior Debt", "terseLabel": "Early repayment of debt" } } }, "localname": "EarlyRepaymentOfSeniorDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r137" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share Basic And Diluted", "terseLabel": "Basic and diluted net loss per ordinary share" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r138", "r139", "r140", "r141" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Net Loss Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureNetLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r421" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10040.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations", "terseLabel": "Effect of exchange rate changes on cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Continuing Operations", "negatedLabel": "Effective tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r40" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfAccruedLiabilitiesDetails": { "order": 10010.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee Related Liabilities Current", "terseLabel": "Accrued compensation and employee-related obligations" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]", "terseLabel": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockBasedCompensationUnderStatementsOfOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r309" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized", "terseLabel": "Compensation cost relating to nonvested shares not yet recognized" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r309" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1", "terseLabel": "Unrecognized expense recognized period" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r306" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Employee Stock Option [Member]", "terseLabel": "Stock Options", "verboseLabel": "Liquidity Event Option Awards" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureNetLossPerShareSummaryOfPotentialGrossOrdinarySharesEquivalentExcludedFromComputationOfNetLossPerShareDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r115", "r116", "r117", "r121", "r129", "r131", "r142", "r198", "r245", "r250", "r316", "r317", "r318", "r343", "r344", "r422", "r423", "r424", "r425", "r426", "r428", "r536", "r537", "r538" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]", "terseLabel": "Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]" } } }, "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFairValuesOfLongTermBorrowingsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "auth_ref": [ "r409", "r413", "r414" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value By Balance Sheet Grouping [Table]", "terseLabel": "Fair Value By Balance Sheet Grouping [Table]" } } }, "localname": "FairValueByBalanceSheetGroupingTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFairValuesOfLongTermBorrowingsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "auth_ref": [ "r409", "r413" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.", "label": "Fair Value By Balance Sheet Grouping [Text Block]", "terseLabel": "Schedule of Fair Values of Long-term Borrowings" } } }, "localname": "FairValueByBalanceSheetGroupingTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r294", "r410", "r451", "r452", "r453" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value By Fair Value Hierarchy Level [Axis]", "terseLabel": "Fair Value Hierarchy and NAV" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r412" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureFairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r286", "r287", "r292", "r294", "r410", "r452" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value Inputs Level2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r294", "r451", "r452", "r453" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Measurements Fair Value Hierarchy [Domain]", "terseLabel": "Fair Value Hierarchy and NAV" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r436", "r437" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails": { "order": 10080.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Finance Lease Liability", "terseLabel": "Finance lease obligation" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r188", "r189", "r204", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months": { "auth_ref": [ "r406" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.", "label": "Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months", "terseLabel": "Pre-tax unrealized loss within OCI to be reclassified to earnings in next 12 months, foreign currency contracts" } } }, "localname": "ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyFairValueHedgeAssetAtFairValue": { "auth_ref": [ "r387" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of all derivative assets designated as foreign currency fair value hedging instruments.", "label": "Foreign Currency Fair Value Hedge Asset At Fair Value", "verboseLabel": "Foreign currency forward contracts" } } }, "localname": "ForeignCurrencyFairValueHedgeAssetAtFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyFairValueHedgeLiabilityAtFairValue": { "auth_ref": [ "r387" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of all derivative liabilities designated as foreign currency fair value hedging instruments.", "label": "Foreign Currency Fair Value Hedge Liability At Fair Value", "verboseLabel": "Foreign currency forward contracts" } } }, "localname": "ForeignCurrencyFairValueHedgeLiabilityAtFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r417", "r418", "r419", "r420" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain Loss Before Tax", "terseLabel": "Foreign currency gain (loss), net" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureOtherExpenseNetAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": { "auth_ref": [ "r103", "r419", "r420" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain Loss Unrealized", "negatedTerseLabel": "Net unrealized gains of foreign currency transaction", "verboseLabel": "Unrealized foreign currency gain (loss), net" } } }, "localname": "ForeignCurrencyTransactionGainLossUnrealized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureOtherExpenseNetAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignExchangeForwardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.", "label": "Foreign Exchange Forward [Member]", "verboseLabel": "Foreign Currency Derivatives" } } }, "localname": "ForeignExchangeForwardMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueExcludingAmortizationOfIntangibleAssetsInStatementsOfOperationsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnauditedParenthetical", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments": { "auth_ref": [ "r385", "r393" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.", "label": "Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments", "terseLabel": "Foreign currency forward contracts" } } }, "localname": "GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfMarkToMarketGainsAndLossesOnNonDesignatedDerivativesRecognizedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnInterestRateCashFlowHedgeIneffectiveness": { "auth_ref": [ "r392" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net gain (loss) during the reporting period due to ineffectiveness in interest rate cash flow hedges. Recognized in earnings.", "label": "Gain Loss On Interest Rate Cash Flow Hedge Ineffectiveness", "terseLabel": "Fair value gains interest rate caps" } } }, "localname": "GainLossOnInterestRateCashFlowHedgeIneffectiveness", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureOtherExpenseNetAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments": { "auth_ref": [ "r385", "r393" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) included in earnings for the period from the increase (decrease) in fair value of interest rate derivatives not designated as hedging instruments.", "label": "Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments", "terseLabel": "Interest rate derivative contracts" } } }, "localname": "GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfMarkToMarketGainsAndLossesOnNonDesignatedDerivativesRecognizedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r102", "r242", "r243" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10170.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gains Losses On Extinguishment Of Debt", "negatedLabel": "Loss on extinguishment of debt", "verboseLabel": "Gain (loss) on early extinguishment of debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2022NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureOtherExpenseNetAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationReconciliationOfNetLossToAdjustedEBITDADetail", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r215", "r216", "r499" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10200.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrantMember": { "auth_ref": [ "r270" ], "lang": { "en-us": { "role": { "documentation": "Award of money not required to be repaid.", "label": "Grant [Member]", "terseLabel": "Grant Revenue" } } }, "localname": "GrantMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r84", "r106", "r158", "r164", "r168", "r171", "r174", "r191", "r415" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited": { "order": 10070.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r382", "r399" ], "lang": { "en-us": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueExcludingAmortizationOfIntangibleAssetsInStatementsOfOperationsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIParentheticalDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfMarkToMarketGainsAndLossesOnNonDesignatedDerivativesRecognizedDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r382" ], "lang": { "en-us": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueExcludingAmortizationOfIntangibleAssetsInStatementsOfOperationsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIParentheticalDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfMarkToMarketGainsAndLossesOnNonDesignatedDerivativesRecognizedDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r382" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueExcludingAmortizationOfIntangibleAssetsInStatementsOfOperationsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIParentheticalDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "I P O [Member]", "terseLabel": "IPO" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r77", "r158", "r164", "r168", "r171", "r174", "r498", "r506", "r511", "r527" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited": { "order": 10010.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest", "totalLabel": "Loss before provision for income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r112", "r158", "r164", "r168", "r171", "r174" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments", "negatedTerseLabel": "Loss incurred before provision for income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueExcludingAmortizationOfIntangibleAssetsInStatementsOfOperationsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIParentheticalDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfMarkToMarketGainsAndLossesOnNonDesignatedDerivativesRecognizedDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockBasedCompensationUnderStatementsOfOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueExcludingAmortizationOfIntangibleAssetsInStatementsOfOperationsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIParentheticalDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfMarkToMarketGainsAndLossesOnNonDesignatedDerivativesRecognizedDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockBasedCompensationUnderStatementsOfOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r334", "r338", "r339", "r348", "r353", "r357", "r358", "r359" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureIncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r107", "r130", "r131", "r156", "r332", "r349", "r355", "r528" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited": { "order": 10020.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense Benefit", "terseLabel": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationReconciliationOfNetLossToAdjustedEBITDADetail", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r101" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10260.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase Decrease In Accounts Payable And Accrued Liabilities", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r101" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10230.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase Decrease In Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r101" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10270.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase Decrease In Deferred Revenue", "terseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r101" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10240.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase Decrease In Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase Decrease In Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r218", "r220" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10210.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets Net Excluding Goodwill", "terseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r75", "r152", "r429", "r432", "r510" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited": { "order": 10040.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "terseLabel": "Interest expense, net", "totalLabel": "Interest expense, net" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueExcludingAmortizationOfIntangibleAssetsInStatementsOfOperationsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationReconciliationOfNetLossToAdjustedEBITDADetail", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interest Expense [Abstract]", "terseLabel": "Interest expense" } } }, "localname": "InterestExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r86", "r241" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails": { "order": 10010.0, "parentTag": "us-gaap_InterestExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense Debt", "terseLabel": "Interest expense" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseMember": { "auth_ref": [ "r397" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing interest expense.", "label": "Interest Expense [Member]", "terseLabel": "Interest Expense, Net" } } }, "localname": "InterestExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueExcludingAmortizationOfIntangibleAssetsInStatementsOfOperationsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r10", "r11", "r40" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfAccruedLiabilitiesDetails": { "order": 10040.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable Current", "terseLabel": "Accrued interest" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": { "auth_ref": [ "r406" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.", "label": "Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net", "terseLabel": "Pre-tax unrealized loss within OCI to be reclassified to earnings in next 12 months, interest rate derivative instruments" } } }, "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateContractMember": { "auth_ref": [ "r286", "r395" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.", "label": "Interest Rate Contract [Member]", "terseLabel": "Interest Rate Derivatives", "verboseLabel": "Interest Rate Derivatives" } } }, "localname": "InterestRateContractMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfDesignatedDerivativeInstrumentsWithinInterestExpenseNetAndCostOfRevenueExcludingAmortizationOfIntangibleAssetsInStatementsOfOperationsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIParentheticalDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnauditedParenthetical", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_InterestRateFairValueHedgeLiabilityAtFairValue": { "auth_ref": [ "r387" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of all derivative liabilities designated as interest rate fair value hedging instruments.", "label": "Interest Rate Fair Value Hedge Liability At Fair Value", "terseLabel": "Interest rate derivative contracts" } } }, "localname": "InterestRateFairValueHedgeLiabilityAtFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]", "terseLabel": "Interest Rate Swap" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r214" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureInventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r48" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails": { "order": 10030.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Inventory Finished Goods", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryGross": { "auth_ref": [ "r51" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Inventory Gross", "totalLabel": "Total Inventories" } } }, "localname": "InventoryGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r4", "r51" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10260.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory Net", "terseLabel": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterialsAndSupplies": { "auth_ref": [ "r50" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails": { "order": 10010.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.", "label": "Inventory Raw Materials And Supplies", "terseLabel": "Raw materials and supplies" } } }, "localname": "InventoryRawMaterialsAndSupplies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r49" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails": { "order": 10020.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Inventory Work In Process", "terseLabel": "Goods in process" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.", "label": "Letters Of Credit Outstanding Amount", "positiveLabel": "Letters of credit, outstanding", "terseLabel": "Letters of credit issued" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r39", "r106", "r166", "r191", "r367", "r372", "r373", "r415" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10010.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r27", "r106", "r191", "r415", "r503", "r520" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities And Stockholders Equity", "totalLabel": "Total liabilities and shareholders\u2019 equity (deficit)" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities And Stockholders Equity [Abstract]", "terseLabel": "Liabilities and Shareholders\u2019 Equity (Deficit)" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r41", "r106", "r191", "r367", "r372", "r373", "r415" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10090.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_LienCategoryAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by category of lien, for example, but not limited to, senior or junior.", "label": "Lien Category [Axis]", "terseLabel": "Lien Category" } } }, "localname": "LienCategoryAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LienCategoryDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Legal claim on the property of another party to secure the payment of a debt or the satisfaction of an obligation by category, for example, but not limited to, senior or junior.", "label": "Lien Category [Domain]", "terseLabel": "Lien Category" } } }, "localname": "LienCategoryDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r17", "r502", "r514" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Line Of Credit", "terseLabel": "Outstanding borrowings" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAxis": { "auth_ref": [ "r37", "r110" ], "lang": { "en-us": { "role": { "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.", "label": "Line Of Credit Facility [Axis]", "terseLabel": "Lender Name" } } }, "localname": "LineOfCreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet": { "auth_ref": [ "r111" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of the credit facility.", "label": "Line Of Credit Facility Increase Decrease For Period Net", "terseLabel": "Line of credit, increase in borrowing capacity" } } }, "localname": "LineOfCreditFacilityIncreaseDecreaseForPeriodNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityLenderDomain": { "auth_ref": [ "r37" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.", "label": "Line Of Credit Facility Lender [Domain]", "terseLabel": "Line of Credit Facility, Lender" } } }, "localname": "LineOfCreditFacilityLenderDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r37" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line Of Credit Facility Maximum Borrowing Capacity", "terseLabel": "Line of credit, maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r37" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line Of Credit Facility Remaining Borrowing Capacity", "terseLabel": "Line of credit, available borrowing capacity" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate L I B O R [Member]", "terseLabel": "LIBOR Rate" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r17", "r239", "r502", "r517" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long Term Debt", "totalLabel": "Total" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "auth_ref": [ "r17" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails2": { "order": 10020.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0 }, "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10100.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.", "label": "Long Term Debt And Capital Lease Obligations", "terseLabel": "Long-term borrowings" } } }, "localname": "LongTermDebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long Term Debt Fair Value", "terseLabel": "Long-term borrowings, fair value" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFairValuesOfLongTermBorrowingsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "auth_ref": [ "r113", "r236" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails": { "order": 10020.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Next Twelve Months", "terseLabel": "2022" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "auth_ref": [ "r113", "r236" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails": { "order": 10050.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Four", "terseLabel": "2025" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "auth_ref": [ "r113", "r236" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails": { "order": 10040.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Three", "terseLabel": "2024" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "auth_ref": [ "r113", "r236" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails": { "order": 10030.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Long Term Debt Maturities Repayments Of Principal In Year Two", "terseLabel": "2023" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "auth_ref": [ "r113" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails": { "order": 10010.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.", "label": "Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year", "terseLabel": "Remainder of 2021" } } }, "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRequiredFutureRepaymentsOfAllBorrowingsOutstandingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r44" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Longterm Debt Type [Axis]", "terseLabel": "Long-term Debt, Type" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2022NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsTables", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFairValuesOfLongTermBorrowingsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r44", "r237" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Longterm Debt Type [Domain]", "terseLabel": "Long-term Debt, Type" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2022NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2025NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfRedemptionPricesOf2028NotesExpressedAsPercentagesOfPrincipalAmountDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsTables", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFairValuesOfLongTermBorrowingsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ManufacturedProductOtherMember": { "auth_ref": [ "r270" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by labor or machinery, classified as other.", "label": "Manufactured Product Other [Member]", "terseLabel": "Other Product Revenue" } } }, "localname": "ManufacturedProductOtherMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.", "label": "Minority Interest Ownership Percentage By Parent", "verboseLabel": "Ownership interest" } } }, "localname": "MinorityInterestOwnershipPercentageByParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r143", "r144" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature Of Operations", "terseLabel": "General and Description of the Business" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r98" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10030.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided By Used In Financing Activities", "totalLabel": "Cash (used in) provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Financing Activities [Abstract]", "terseLabel": "Cash Flows from Financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r98" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10020.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided By Used In Investing Activities", "totalLabel": "Cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Investing Activities [Abstract]", "terseLabel": "Cash Flows from Investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r98", "r99", "r103" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10010.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided By Used In Operating Activities", "terseLabel": "Cash provided by operating activities", "totalLabel": "Cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Operating Activities [Abstract]", "terseLabel": "Cash Flows from Operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r68", "r71", "r80", "r103", "r106", "r120", "r125", "r126", "r127", "r128", "r130", "r131", "r136", "r158", "r164", "r168", "r171", "r174", "r191", "r415", "r507", "r524" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 10010.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income Loss", "terseLabel": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationReconciliationOfNetLossToAdjustedEBITDADetail", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgeDerivativeLiabilitiesAtFairValue": { "auth_ref": [ "r387" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of all derivative liabilities designated as hedges of net investment in foreign operations.", "label": "Net Investment Hedge Derivative Liabilities At Fair Value", "terseLabel": "Net investment in a foreign operation, designated as economic hedge" } } }, "localname": "NetInvestmentHedgeDerivativeLiabilitiesAtFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r381" ], "lang": { "en-us": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Net Investment Hedge" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r118", "r119", "r122", "r123", "r133", "r134", "r135", "r199", "r200", "r277", "r278", "r279", "r280", "r319", "r345", "r346", "r347", "r483", "r484", "r485", "r540", "r541", "r542", "r543", "r545" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.", "label": "New Accounting Pronouncements And Changes In Accounting Principles [Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRecentAccountingPronouncements" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash Investing And Financing Items [Abstract]" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r382" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Nondesignated [Member]", "terseLabel": "Not Designated as Hedging Instrument" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfCurrencyHedgingInstrumentsOutstandingDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfInterestRateDerivativeAgreementsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfMarkToMarketGainsAndLossesOnNonDesignatedDerivativesRecognizedDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "domainItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r146" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number Of Reportable Segments", "terseLabel": "Number of reportable segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r158", "r164", "r168", "r171", "r174" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited": { "order": 10030.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income Loss", "totalLabel": "Income from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r436" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfAccruedLiabilitiesDetails": { "order": 10060.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease Liability Current", "terseLabel": "Current portion of operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r163", "r164", "r165", "r166", "r168", "r174" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization Consolidation And Presentation Of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r9", "r10", "r11", "r40" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfAccruedLiabilitiesDetails": { "order": 10080.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities Current", "terseLabel": "Other accrued liabilities" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r52" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10270.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r34" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10230.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r66", "r74", "r422", "r424", "r428" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails": { "order": 10010.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income Loss Before Reclassifications Net Of Tax", "terseLabel": "Current period deferrals" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeTax": { "auth_ref": [ "r81", "r190", "r422", "r427", "r428", "r508", "r525" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 10030.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income Loss Before Tax", "totalLabel": "Other comprehensive income (loss), before tax" } } }, "localname": "OtherComprehensiveIncomeLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income Loss Before Tax Portion Attributable To Parent [Abstract]", "terseLabel": "Other comprehensive income (loss), before tax:" } } }, "localname": "OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "auth_ref": [ "r60", "r63" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax", "terseLabel": "Derivatives, net of tax of $0.0" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax": { "auth_ref": [ "r60", "r63" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 10050.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax", "terseLabel": "Derivatives" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": { "auth_ref": [ "r64" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax", "terseLabel": "Derivatives, tax" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnauditedParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "auth_ref": [ "r60", "r63", "r386", "r390", "r403" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax", "terseLabel": "Amount of loss (gain) recognized in OCI on hedges" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfGainsAndLossesFromDesignatedDerivativeAndNonDerivativeInstrumentsWithinAOCIParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": { "auth_ref": [ "r58", "r63" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 10070.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax", "terseLabel": "Foreign currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r58" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax", "terseLabel": "Foreign currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r69", "r72", "r74", "r81", "r245", "r422", "r427", "r428", "r508", "r525" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 10020.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income Loss Net Of Tax", "totalLabel": "Other comprehensive income (loss), net of tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossTax": { "auth_ref": [ "r64", "r81", "r332", "r354", "r356", "r422", "r425", "r428", "r508", "r525" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited": { "order": 10040.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).", "label": "Other Comprehensive Income Loss Tax", "terseLabel": "Income tax provision related to items of other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentAssetsMember": { "auth_ref": [ "r384", "r402" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current assets.", "label": "Other Current Assets [Member]", "terseLabel": "Other Current Assets" } } }, "localname": "OtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueScheduleOfBalanceOfContractAssetsRecordedInConsolidatedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherIncomeAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income And Expenses [Abstract]" } } }, "localname": "OtherIncomeAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r45" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10120.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities Noncurrent", "terseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLongTermDebt": { "auth_ref": [ "r17", "r502", "r517" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails": { "order": 10100.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt classified as other.", "label": "Other Long Term Debt", "terseLabel": "Other long-term borrowings" } } }, "localname": "OtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r103" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10220.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income Expense", "negatedLabel": "Other non-cash, net" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent assets.", "label": "Other Noncurrent Assets [Member]", "terseLabel": "Other Assets" } } }, "localname": "OtherNoncurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueScheduleOfBalanceOfContractAssetsRecordedInConsolidatedBalanceSheetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Member]", "terseLabel": "Other Liabilities" } } }, "localname": "OtherNoncurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesLocationAndFairValuesOfNonDesignatedHedgingInstrumentsRecognizedWithinConsolidatedBalanceSheetsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r87" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited": { "order": 10060.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income Expense", "negatedLabel": "Other expense, net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureOtherExpenseNetAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).", "label": "Other Nonoperating Income Expense [Member]", "terseLabel": "Other Expense, Net" } } }, "localname": "OtherNonoperatingIncomeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesScheduleOfMarkToMarketGainsAndLossesOnNonDesignatedDerivativesRecognizedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherOperatingIncomeAndExpenseTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other operating income and other operating expense items.", "label": "Other Operating Income And Expense [Text Block]", "terseLabel": "Other Expense, Net" } } }, "localname": "OtherOperatingIncomeAndExpenseTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureOtherExpenseNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherOperatingIncomeExpenseNet": { "auth_ref": [], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited": { "order": 10110.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.", "label": "Other Operating Income Expense Net", "negatedLabel": "Other operating expense, net" } } }, "localname": "OtherOperatingIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherShortTermBorrowings": { "auth_ref": [ "r35" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails": { "order": 10090.0, "parentTag": "us-gaap_DebtAndCapitalLeaseObligations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowings classified as other, maturing within one year or the normal operating cycle, if longer.", "label": "Other Short Term Borrowings", "terseLabel": "Other short-term borrowings" } } }, "localname": "OtherShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over Allotment Option [Member]", "terseLabel": "Underwriters Option" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentForManagementFee": { "auth_ref": [ "r96", "r441" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount paid to managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).", "label": "Payment For Management Fee", "terseLabel": "Annual management fee" } } }, "localname": "PaymentForManagementFee", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentOfFinancingAndStockIssuanceCosts": { "auth_ref": [ "r95" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10060.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total of the cash outflow during the period which has been paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt and the cost incurred directly for the issuance of equity securities.", "label": "Payment Of Financing And Stock Issuance Costs", "negatedLabel": "Payment of initial public offering costs" } } }, "localname": "PaymentOfFinancingAndStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForHedgeInvestingActivities": { "auth_ref": [ "r90", "r100" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.", "label": "Payments For Hedge Investing Activities", "terseLabel": "Net settlement on derivatives" } } }, "localname": "PaymentsForHedgeInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtExtinguishmentCosts": { "auth_ref": [ "r94" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.", "label": "Payments Of Debt Extinguishment Costs", "terseLabel": "Redemption premium", "verboseLabel": "Redemption premium" } } }, "localname": "PaymentsOfDebtExtinguishmentCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r89" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10110.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments To Acquire Property Plant And Equipment", "negatedLabel": "Purchases of property, plant and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": { "auth_ref": [ "r18", "r282", "r283", "r284", "r294" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10110.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.", "label": "Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent", "terseLabel": "Employee-related obligations" } } }, "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred Redeemable Shares" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock Par Or Stated Value Per Share", "terseLabel": "Preferred stock, nominal value per share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r19" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10040.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock Value", "terseLabel": "Preferred redeemable shares, $1.39 nominal value per share, 50,000 and no shares issued and outstanding as of July 4, 2021 and January 3, 2021, respectively" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r91" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10050.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds From Issuance Initial Public Offering", "terseLabel": "Proceeds from initial public offering", "verboseLabel": "Net proceeds from IPO" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r92" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10070.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds From Issuance Of Long Term Debt", "terseLabel": "Proceeds from long-term borrowings" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r91", "r311" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10100.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds From Stock Options Exercised", "terseLabel": "Proceeds from exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r1", "r68", "r71", "r97", "r106", "r120", "r130", "r131", "r158", "r164", "r168", "r171", "r174", "r191", "r365", "r368", "r369", "r374", "r375", "r415", "r511" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10140.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Profit Loss", "terseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r13", "r14", "r223", "r521" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10190.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property Plant And Equipment Net", "terseLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "auth_ref": [ "r66", "r67", "r74", "r422", "r426", "r428" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails": { "order": 10020.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax", "negatedLabel": "Amounts reclassified to net loss" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": { "auth_ref": [ "r164", "r168" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.", "label": "Reconciliation Of Operating Profit Loss From Segments To Consolidated [Text Block]", "terseLabel": "Reconciliation of Net Loss to Adjusted EBITDA" } } }, "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r293", "r441", "r442" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r293", "r441", "r442", "r444" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]", "terseLabel": "Related Party Transaction" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r293" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]", "terseLabel": "Related Party Transaction" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r293", "r441", "r444", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party Transactions By Related Party [Axis]", "terseLabel": "Related Party" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r439", "r440", "r442", "r445", "r446" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r93" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments Of Debt", "terseLabel": "Repayment of debt", "verboseLabel": "Repayment of debt" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2022NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r93" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10080.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments Of Long Term Debt", "negatedLabel": "Payments on long-term borrowings" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfSeniorDebt": { "auth_ref": [ "r93" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.", "label": "Repayments Of Senior Debt", "terseLabel": "Repayments of senior debt" } } }, "localname": "RepaymentsOfSeniorDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfShortTermDebt": { "auth_ref": [ "r93" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10090.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Repayments Of Short Term Debt", "negatedLabel": "Payments on short-term borrowings, net" } } }, "localname": "RepaymentsOfShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r326", "r558" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited": { "order": 10090.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research And Development Expense", "terseLabel": "Research and development expense" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research And Development Expense [Member]", "terseLabel": "Research and development expense" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockBasedCompensationUnderStatementsOfOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashEquivalentsNoncurrent": { "auth_ref": [ "r8", "r15", "r105", "r548" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfCashAndCashEquivalentsAndRestrictedCashDetails": { "order": 10020.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash Equivalents Noncurrent", "terseLabel": "Restricted cash included in Other assets" } } }, "localname": "RestrictedCashEquivalentsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationScheduleOfCashAndCashEquivalentsAndRestrictedCashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Restricted Stock" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringCosts": { "auth_ref": [ "r102" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Costs", "terseLabel": "Restructuring and severance-related costs" } } }, "localname": "RestructuringCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationReconciliationOfNetLossToAdjustedEBITDADetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r23", "r250", "r320", "r519", "r540", "r545" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10070.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings Accumulated Deficit", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r115", "r116", "r117", "r121", "r129", "r131", "r198", "r316", "r317", "r318", "r343", "r344", "r536", "r538" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue From Contract With Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r149", "r150", "r163", "r169", "r170", "r177", "r178", "r182", "r264", "r266", "r479" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails": { "order": 10010.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue From Contract With Customer Excluding Assessed Tax", "verboseLabel": "Total Product Revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r269", "r281" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue From Contract With Customer [Text Block]", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "auth_ref": [ "r180" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.", "label": "Revenue From External Customers By Geographic Areas Table [Text Block]", "terseLabel": "Net Revenue by Segment" } } }, "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueNotFromContractWithCustomer": { "auth_ref": [ "r76" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails": { "order": 10020.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue that is not accounted for under Topic 606.", "label": "Revenue Not From Contract With Customer", "positiveLabel": "Revenue recognized", "terseLabel": "Collaborations and Other Revenue" } } }, "localname": "RevenueNotFromContractWithCustomer", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r76", "r106", "r149", "r150", "r163", "r169", "r170", "r177", "r178", "r182", "r191", "r415", "r511" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited": { "order": 10120.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Net revenue", "totalLabel": "Net Revenue", "verboseLabel": "Net Revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueSummaryOfNetRevenueByLineOfBusinessDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsComponentsOfBorrowingsDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsScheduleOfInterestExpenseNetDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleLeasebackTransactionLeaseTerms": { "auth_ref": [ "r434", "r438" ], "lang": { "en-us": { "role": { "documentation": "A description of the terms of the lease(s) related to the assets being leased-back in connection with the transaction involving the sale of property to another party and the lease of the property back to the seller.", "label": "Sale Leaseback Transaction Lease Terms", "terseLabel": "Initial term" } } }, "localname": "SaleLeasebackTransactionLeaseTerms", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSaleAndLeasebackFinancingAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SaleLeasebackTransactionMonthlyRentalPayments": { "auth_ref": [ "r434" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the monthly rental payments due under the lease entered into in connection with the transactions involving the sale of property to another party and the lease of the property back to the seller.", "label": "Sale Leaseback Transaction Monthly Rental Payments", "terseLabel": "Monthly rental payments" } } }, "localname": "SaleLeasebackTransactionMonthlyRentalPayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSaleAndLeasebackFinancingAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale Of Stock Name Of Transaction [Domain]", "terseLabel": "Sale of Stock" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule Of Accrued Liabilities Table [Text Block]", "terseLabel": "Schedule of Accrued Liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r66", "r427", "r428" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule Of Accumulated Other Comprehensive Income Loss Table [Text Block]", "terseLabel": "Summary of Accumulated Other Comprehensive Income (Loss), Net of Tax" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]", "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureNetLossPerShareSummaryOfPotentialGrossOrdinarySharesEquivalentExcludedFromComputationOfNetLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]", "terseLabel": "Summary of Potential Gross Ordinary Shares Equivalent Excluded from Computation of Net Loss Per Share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureNetLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.", "label": "Schedule Of Cash Flow Hedging Instruments Statements Of Financial Performance And Financial Position Location Table [Text Block]", "terseLabel": "Location and Fair Values of Designated and Non-Designated Hedging Instruments Recognized within Consolidated Balance Sheets" } } }, "localname": "ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r362" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]", "terseLabel": "Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.", "label": "Schedule Of Compensation Cost For Share Based Payment Arrangements Allocation Of Share Based Compensation Costs By Plan Table [Text Block]", "terseLabel": "Schedule of Stock-Based Compensation Under Statements Of Operations" } } }, "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule Of Debt Table [Text Block]", "terseLabel": "Components of Borrowings" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r390" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.", "label": "Schedule Of Derivative Instruments Effect On Other Comprehensive Income Loss Table [Text Block]", "terseLabel": "Schedule of Designated Derivative Instruments within Interest Expense, Net and Cost of Revenue, Excluding Amortization of Intangible Assets in Statements of Operations" } } }, "localname": "ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r385", "r394", "r399" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Schedule Of Derivative Instruments Gain Loss In Statement Of Financial Performance [Text Block]", "terseLabel": "Schedule of Gains and Losses from Designated Derivative and Non-derivative Instruments" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r300", "r307", "r321" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]", "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockBasedCompensationUnderStatementsOfOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of interest rate derivatives, including, but not limited to, the fair value of the derivatives, statement of financial position location, and statement of financial performance location of these instruments.", "label": "Schedule Of Interest Rate Derivatives Table [Text Block]", "terseLabel": "Schedule of Interest Rate Derivative Agreements" } } }, "localname": "ScheduleOfInterestRateDerivativesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r12", "r30", "r31", "r32" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule Of Inventory Current Table [Text Block]", "terseLabel": "Schedule of Inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureInventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "auth_ref": [ "r236" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.", "label": "Schedule Of Maturities Of Long Term Debt Table [Text Block]", "terseLabel": "Schedule of Required Future Repayments of all Borrowings Outstanding" } } }, "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r108", "r443", "r444" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule Of Related Party Transactions By Related Party [Table]", "terseLabel": "Schedule Of Related Party Transactions By Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r158", "r161", "r167", "r217" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule Of Segment Reporting Information By Segment [Table]", "terseLabel": "Schedule Of Segment Reporting Information By Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r158", "r161", "r167", "r217" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule Of Segment Reporting Information By Segment [Text Block]", "terseLabel": "Adjusted EBITDA by Segment" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r301", "r310" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]", "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SecurityDeposit": { "auth_ref": [ "r53" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of an asset, typically cash, provided to a counterparty to provide certain assurance of performance by the entity pursuant to the terms of a written or oral agreement, such as a lease.", "label": "Security Deposit", "terseLabel": "Security deposit" } } }, "localname": "SecurityDeposit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSaleAndLeasebackFinancingAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r145", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r163", "r164", "r165", "r166", "r168", "r169", "r170", "r171", "r172", "r174", "r182", "r529" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segment [Domain]", "terseLabel": "Segments" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r145", "r147", "r148", "r158", "r162", "r168", "r172", "r173", "r174", "r175", "r177", "r181", "r182", "r183" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment and Geographic Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationAdjustedEBITDABySegmentDetail", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r85" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited": { "order": 10080.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling General And Administrative Expense", "terseLabel": "Selling, marketing and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling General And Administrative Expenses [Member]", "terseLabel": "Selling, marketing and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockBasedCompensationUnderStatementsOfOperationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r101" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10190.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share Based Compensation", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationReconciliationOfNetLossToAdjustedEBITDADetail", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r302" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1", "terseLabel": "Shares, vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period", "terseLabel": "Additional shares granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]", "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r299", "r303" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]", "terseLabel": "Award Type" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Ordinary shares, price per share" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r302" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage", "terseLabel": "Percentage of vesting award accelerated" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r245" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares Issued", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StandbyLettersOfCreditMember": { "auth_ref": [ "r234", "r235", "r364", "r546" ], "lang": { "en-us": { "role": { "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation.", "label": "Standby Letters Of Credit [Member]", "verboseLabel": "Letters of Credit" } } }, "localname": "StandbyLettersOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r0", "r145", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r163", "r164", "r165", "r166", "r168", "r169", "r170", "r171", "r172", "r174", "r182", "r217", "r225", "r226", "r227", "r529" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Statement Business Segments [Axis]", "terseLabel": "Segments" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSegmentAndGeographicInformationNetRevenueBySegmentDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r47", "r115", "r116", "r117", "r121", "r129", "r131", "r142", "r198", "r245", "r250", "r316", "r317", "r318", "r343", "r344", "r422", "r423", "r424", "r425", "r426", "r428", "r536", "r537", "r538" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Statement Equity Components [Axis]", "terseLabel": "Equity Components", "verboseLabel": "Ordinary Shares" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesTables", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnauditedParenthetical", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Income And Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Stockholders Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r115", "r116", "r117", "r142", "r479" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureDerivativeInstrumentsAndHedgingActivitiesTables", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnauditedParenthetical", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r19", "r20", "r245", "r250" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period Shares New Issues", "terseLabel": "Issuance of ordinary shares upon completion of initial public offering, net of commissions, underwriting discounts and offering costs, shares", "verboseLabel": "Ordinary shares issued and sold" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period Shares Other", "positiveTerseLabel": "Initial share capital", "terseLabel": "Issuance of incorporation shares consisting of ordinary shares and preferred redeemable shares, shares" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r19", "r20", "r245", "r250", "r304" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Stock Issued During Period Shares Stock Options Exercised", "terseLabel": "Exercise of stock options, shares" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockSplits": { "auth_ref": [ "r19", "r20", "r245", "r250" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of a stock split.", "label": "Stock Issued During Period Shares Stock Splits", "terseLabel": "Stock issued during period, shares, stock splits" } } }, "localname": "StockIssuedDuringPeriodSharesStockSplits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBasisOfPresentationOfUnauditedConsolidatedFinancialStatementsAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r19", "r20", "r245", "r250" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period Value New Issues", "terseLabel": "Issuance of ordinary shares upon completion of initial public offering, net of commissions, underwriting discounts and offering costs" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period Value Other", "terseLabel": "Issuance of incorporation shares consisting of ordinary share and preferred redeemable shares" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r47", "r245", "r250" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period Value Stock Options Exercised", "terseLabel": "Exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r20", "r25", "r26", "r106", "r187", "r191", "r415" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited": { "order": 10030.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders Equity", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total shareholders\u2019 equity (deficit)" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureAccumulatedOtherComprehensiveIncomeLossSummaryOfAccumulatedOtherComprehensiveIncomeLossNetOfTaxDetails", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited", "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfChangesInShareholdersEquityDeficitUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders Equity [Abstract]", "terseLabel": "Shareholders\u2019 Equity (Deficit):" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedBalanceSheetsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": { "auth_ref": [ "r251" ], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.", "label": "Stockholders Equity Note Stock Split Conversion Ratio1", "terseLabel": "Stock split conversion ratio" } } }, "localname": "StockholdersEquityNoteStockSplitConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBasisOfPresentationOfUnauditedConsolidatedFinancialStatementsAdditionalInformationDetails" ], "xbrltype": "pureItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Subsidiary Sale Of Stock [Axis]", "terseLabel": "Sale of Stock" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureGeneralAndDescriptionOfBusinessAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "terseLabel": "Supplemental Balance Sheet Information" } } }, "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureSupplementalBalanceSheetInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_TaxAdjustmentsSettlementsAndUnusualProvisions": { "auth_ref": [ "r327", "r328" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) to previously recorded tax expense. Includes, but is not limited to, significant settlements of income tax disputes, and unusual tax positions or infrequent actions taken by the entity, including tax assessment reversal, and IRS tax settlement.", "label": "Tax Adjustments Settlements And Unusual Provisions", "terseLabel": "Interest and penalties" } } }, "localname": "TaxAdjustmentsSettlementsAndUnusualProvisions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r188", "r189", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Transfers And Servicing Of Financial Instruments Types Of Financial Instruments [Domain]", "terseLabel": "Financial Instruments" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r120", "r121", "r122", "r124", "r195", "r196", "r197", "r198", "r201", "r202", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r320", "r341", "r342", "r343", "r344", "r480", "r481", "r482", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Type Of Adoption [Member]", "terseLabel": "Accounting Standards Update" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRecentAccountingPronouncementsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r362" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Type Of Arrangement [Axis]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsSeniorSecuredCreditFacilitiesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureCollaborationsAndOtherRelationshipsAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureRevenueAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax": { "auth_ref": [ "r390" ], "calculation": { "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10160.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of net unrealized gain (loss) related to the change in fair value of foreign currency exchange rate derivatives designated as cash flow hedging instruments. Recorded in accumulated other comprehensive income to the extent that the cash flow hedge is determined to be effective.", "label": "Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax", "negatedLabel": "Unrealized foreign exchange (gains) losses, net" } } }, "localname": "UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r329", "r336" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r335" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued", "terseLabel": "Accrued interest and penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "auth_ref": [ "r337" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.", "label": "Unrecognized Tax Benefits That Would Impact Effective Tax Rate", "terseLabel": "Unrecognized tax benefits that would affect effective income tax rate" } } }, "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangementsAccountsReceivableFinancingAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number Of Share Outstanding Basic And Diluted", "terseLabel": "Basic and diluted weighted-average ordinary shares outstanding" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/StatementConsolidatedStatementsOfOperationsUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_WriteOffOfDeferredDebtIssuanceCost": { "auth_ref": [ "r86" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.", "label": "Write Off Of Deferred Debt Issuance Cost", "terseLabel": "Write off of deferred debt Issuance cost" } } }, "localname": "WriteOffOfDeferredDebtIssuanceCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2025NotesAdditionalInformationDetails", "http://orthoclinical.com/20210704/taxonomy/role/DisclosureBorrowingsAndOtherArrangements2028NotesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" } }, "unitCount": 9 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3581-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04.(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r114": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=d3e31010-122693" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=d3e31137-122693" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=SL108384541-122693" }, "r135": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r141": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r144": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8475-108599" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "a", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r183": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL120254519-210437" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL120320025-210437" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL120320025-210437" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r214": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r233": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121596127&loc=d3e12803-110250" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629" }, "r244": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 4.C)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130533-203044" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(i)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r281": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1731-114919" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907" }, "r324": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6419918&loc=d3e35281-107843" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121573983&loc=d3e28511-109314" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121573983&loc=d3e28446-109314" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "740" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "740" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "740" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e39076-109324" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r359": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r363": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "808", "URI": "http://asc.fasb.org/topic&trid=5833765" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116873149&loc=d3e923-111674" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(6)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121483254&loc=SL120254523-199619" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80845-113994" }, "r408": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=120240428&loc=SL120254526-165497" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30226-110892" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121586228&loc=d3e50796-112755" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL120154346-209984" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121606570&loc=SL77919786-209982" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r446": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(1)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(2)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(f)(3)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(4),(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.13,16)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.16)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8,17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=66023616&loc=SL35737432-115832" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r559": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r560": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r561": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r562": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r563": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r564": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r57": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "210", "URI": "http://asc.fasb.org/topic&trid=2122208" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(2)(a))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(2)(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r88": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "http://asc.fasb.org/topic&trid=2134417" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" } }, "version": "2.1" }